Reiner Siebert

Q: What Schools Are Affiliated With Reiner Siebert

Reiner Siebert is affiliated with the following schools: Institute of Cancer Research, University of Ulm, McGill University, Kiel University, University of Valencia, University of Navarra, University of Birmingham

Reiner Siebert's AcademicInfluence.com Rankings

Reiner Siebert

Biology

#7429

World Rank

#10354

Historical Rank

Computational Biology

#139

World Rank

#139

Historical Rank

Genetics

#710

World Rank

#802

Historical Rank

biology Degrees

Download Badge

Biology

Why Is Reiner Siebert Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Reiner Siebert's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Signatures of mutational processes in human cancer (2013) (7589)
The 2016 revision of the World Health Organization classification of lymphoid neoplasms. (2016) (5445)
Microbial Exposure During Early Life Has Persistent Effects on Natural Killer T Cell Function (2012) (1393)
Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes (2018) (974)
A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling. (2006) (966)
The landscape of genomic alterations across childhood cancers (2018) (880)
A physical map of the human genome (2001) (753)
Identification of the familial cylindromatosis tumour-suppressor gene (2000) (683)
Epigenome-wide association study of body mass index, and the adverse outcomes of adiposity (2016) (634)
Double-hit B-cell lymphomas. (2011) (630)
Changes in the pattern of DNA methylation associate with twin discordance in systemic lupus erythematosus. (2010) (614)
Lymphomas with concurrent BCL2 and MYC translocations: the critical factors associated with survival. (2009) (561)
Obesity accelerates epigenetic aging of human liver (2014) (557)
MYC status in concert with BCL2 and BCL6 expression predicts outcome in diffuse large B-cell lymphoma. (2013) (487)
Deregulated expression of cytokine receptor gene, CRLF2, is involved in lymphoid transformation in B-cell precursor acute lymphoblastic leukemia. (2009) (479)
Landscape of somatic mutations and clonal evolution in mantle cell lymphoma (2013) (472)
TNFAIP3 (A20) is a tumor suppressor gene in Hodgkin lymphoma and primary mediastinal B cell lymphoma (2009) (468)
Recurrent mutation of the ID3 gene in Burkitt lymphoma identified by integrated genome, exome and transcriptome sequencing (2012) (404)
Inactivating mutations and overexpression of BCL10, a caspase recruitment domain-containing gene, in MALT lymphoma with t(1;14)(p22;q32) (1999) (400)
DNA methylation analysis in nonalcoholic fatty liver disease suggests distinct disease-specific and remodeling signatures after bariatric surgery. (2013) (384)
Atypical Teratoid/Rhabdoid Tumors Are Comprised of Three Epigenetic Subgroups with Distinct Enhancer Landscapes. (2016) (374)
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms (2022) (373)
Variable frequencies of MALT lymphoma-associated genetic aberrations in MALT lymphomas of different sites (2004) (368)
The International Human Epigenome Consortium: A Blueprint for Scientific Collaboration and Discovery (2016) (360)
A DNA methylation fingerprint of 1628 human samples. (2011) (359)
Germline and somatic SMARCA4 mutations characterize small cell carcinoma of the ovary, hypercalcemic type (2014) (356)
Cyclin D1-negative mantle cell lymphoma: a clinicopathologic study based on gene expression profiling. (2005) (335)
BLUEPRINT to decode the epigenetic signature written in blood (2012) (320)
Variable frequencies of t(11;18)(q21;q21) in MALT lymphomas of different sites: significant association with CagA strains of H pylori in gastric MALT lymphoma. (2003) (320)
Mutations in the LGI1/Epitempin gene on 10q24 cause autosomal dominant lateral temporal epilepsy. (2002) (313)
Derepression of an endogenous long terminal repeat activates the CSF1R proto-oncogene in human lymphoma (2010) (310)
The BCL11 gene family: involvement of BCL11A in lymphoid malignancies. (2001) (308)
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms (2022) (293)
Epigenetic silencing of the tumor suppressor microRNA Hsa-miR-124a regulates CDK6 expression and confers a poor prognosis in acute lymphoblastic leukemia. (2009) (292)
FISH analysis for the detection of lymphoma-associated chromosomal abnormalities in routine paraffin-embedded tissue. (2006) (283)
Synergy between PI3K signaling and MYC in Burkitt lymphomagenesis. (2012) (278)
ALK-positive diffuse large B-cell lymphoma is associated with Clathrin-ALK rearrangements: report of 6 cases. (2003) (271)
Whole-genome fingerprint of the DNA methylome during human B cell differentiation (2015) (265)
Germline nonsense mutation and somatic inactivation of SMARCA4/BRG1 in a family with rhabdoid tumor predisposition syndrome. (2010) (265)
Homozygous deletions localize novel tumor suppressor genes in B-cell lymphomas. (2007) (264)
Mutation status of the residual ATM allele is an important determinant of the cellular response to chemotherapy and survival in patients with chronic lymphocytic leukemia containing an 11q deletion. (2007) (259)
Quantitative comparison of DNA methylation assays for biomarker development and clinical applications (2016) (251)
Classical Hodgkin lymphoma is characterized by recurrent copy number gains of the short arm of chromosome 2. (2002) (248)
Molecular remission is an independent predictor of clinical outcome in patients with mantle cell lymphoma after combined immunochemotherapy: a European MCL intergroup study. (2010) (248)
Recurrent involvement of the REL and BCL11A loci in classical Hodgkin lymphoma. (2002) (243)
Molecular subsets of mantle cell lymphoma defined by the IGHV mutational status and SOX11 expression have distinct biologic and clinical features. (2012) (238)
Presence of the P2RY8-CRLF2 rearrangement is associated with a poor prognosis in non-high-risk precursor B-cell acute lymphoblastic leukemia in children treated according to the ALL-BFM 2000 protocol. (2010) (224)
High proportion of large genomic deletions and a genotype–phenotype update in 80 unrelated families with juvenile polyposis syndrome (2007) (222)
Genomic basis for RNA alterations in cancer (2020) (221)
Translocations activating IRF4 identify a subtype of germinal center-derived B-cell lymphoma affecting predominantly children and young adults. (2011) (221)
Mantle-cell lymphoma genotypes identified with CGH to BAC microarrays define a leukemic subgroup of disease and predict patient outcome. (2005) (207)
Nonsense mutation and inactivation of SMARCA4 (BRG1) in an atypical teratoid/rhabdoid tumor showing retained SMARCB1 (INI1) expression. (2011) (206)
An imprinted locus associated with transient neonatal diabetes mellitus. (2000) (206)
Five members of the CEBP transcription factor family are targeted by recurrent IGH translocations in B-cell precursor acute lymphoblastic leukemia (BCP-ALL). (2007) (205)
Translocations involving 8q24 in Burkitt lymphoma and other malignant lymphomas: a historical review of cytogenetics in the light of todays knowledge (2008) (204)
Aberrant immunoglobulin class switch recombination and switch translocations in activated B cell–like diffuse large B cell lymphoma (2007) (199)
MYC-IG rearrangements are negative predictors of survival in DLBCL patients treated with immunochemotherapy: a GELA/LYSA study. (2015) (197)
MALT1 is deregulated by both chromosomal translocation and amplification in B-cell non-Hodgkin lymphoma. (2003) (197)
The novel human beta-defensin-3 is widely expressed in oral tissues. (2002) (191)
Structural aberrations affecting the MYC locus indicate a poor prognosis independent of clinical risk factors in diffuse large B-cell lymphomas treated within randomized trials of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL) (2008) (183)
Gains of 2p involving the REL locus correlate with nuclear c-Rel protein accumulation in neoplastic cells of classical Hodgkin lymphoma. (2003) (181)
Hodgkin's lymphoma cell lines are characterized by frequent aberrations on chromosomes 2p and 9p including REL and JAK2 (2003) (169)
Quantitative assessment of molecular remission after high-dose therapy with autologous stem cell transplantation predicts long-term remission in mantle cell lymphoma. (2006) (167)
Series THE UPDATED WHO CLASSIFICATION OF HEMATOLOGICAL MALIGNANCIES The 2016 revision of the World Health Organization classi fi cation of lymphoid neoplasms (2016) (166)
A maternal hypomethylation syndrome presenting as transient neonatal diabetes mellitus (2006) (165)
Screening 500 unselected neurofibromatosis 1 patients for deletions of the NF1 gene (2004) (165)
CCND2 rearrangements are the most frequent genetic events in cyclin D1(-) mantle cell lymphoma. (2013) (164)
A recurrent 11q aberration pattern characterizes a subset of MYC-negative high-grade B-cell lymphomas resembling Burkitt lymphoma. (2014) (162)
Biological characterization of adult MYC-translocation-positive mature B-cell lymphomas other than molecular Burkitt lymphoma (2014) (159)
Characterization of 8p21.3 chromosomal deletions in B-cell lymphoma: TRAIL-R1 and TRAIL-R2 as candidate dosage-dependent tumor suppressor genes. (2005) (158)
Fine mapping of the 1p36 deletion syndrome identifies mutation of PRDM16 as a cause of cardiomyopathy. (2013) (157)
Activating L265P mutations of the MYD88 gene are common in primary central nervous system lymphoma (2011) (157)
Patient age at diagnosis is associated with the molecular characteristics of diffuse large B-cell lymphoma. (2012) (156)
Diffuse large B-cell lymphoma in pediatric patients belongs predominantly to the germinal-center type B-cell lymphomas: a clinicopathologic analysis of cases included in the German BFM (Berlin-Frankfurt-Munster) Multicenter Trial. (2006) (155)
Recurrent finding of the FIP1L1-PDGFRA fusion gene in eosinophilia-associated acute myeloid leukemia and lymphoblastic T-cell lymphoma (2007) (154)
Modern concepts in the biology, diagnosis, differential diagnosis and treatment of primary central nervous system lymphoma (2011) (153)
New insights into the biology and origin of mature aggressive B-cell lymphomas by combined epigenomic, genomic, and transcriptional profiling. (2009) (151)
Inv(2)(p23q35) in anaplastic large-cell lymphoma induces constitutive anaplastic lymphoma kinase (ALK) tyrosine kinase activation by fusion to ATIC, an enzyme involved in purine nucleotide biosynthesis. (2000) (150)
Gene expression profiling suggests primary central nervous system lymphomas to be derived from a late germinal center B cell (2008) (150)
Follicular lymphoma grade 3B is a distinct neoplasm according to cytogenetic and immunohistochemical profiles (2011) (149)
Recurrent mTORC1-activating RRAGC mutations in follicular lymphoma (2015) (143)
Non-nodal type of mantle cell lymphoma is a specific biological and clinical subgroup of the disease (2012) (142)
A Comprehensive Microarray-Based DNA Methylation Study of 367 Hematological Neoplasms (2009) (139)
Cyclin D3 is a target gene of t(6;14)(p21.1;q32.3) of mature B-cell malignancies. (2001) (139)
Rare variants in NR2F2 cause congenital heart defects in humans. (2014) (138)
MALT lymphoma with t(14;18)(q32;q21)/IGH‐MALT1 is characterized by strong cytoplasmic MALT1 and BCL10 expression (2005) (137)
High incidence of chromosomal imbalances and gene amplifications in the classical follicular variant of follicle center lymphoma. (1996) (136)
Epigenetic regulation of microRNAs in acute lymphoblastic leukemia. (2009) (136)
Identification of cytogenetic subgroups and karyotypic pathways of clonal evolution in follicular lymphomas (2004) (136)
Genomic profiling reveals different genetic aberrations in systemic ALK‐positive and ALK‐negative anaplastic large cell lymphomas (2008) (135)
High‐resolution genomic analysis suggests the absence of recurrent genomic alterations other than SMARCB1 aberrations in atypical teratoid/rhabdoid tumors (2013) (134)
The reference epigenome and regulatory chromatin landscape of chronic lymphocytic leukemia (2018) (131)
SMARCA4-mutated atypical teratoid/rhabdoid tumors are associated with inherited germline alterations and poor prognosis (2014) (131)
Mapping of the gene encoding human beta-defensin-2 (DEFB2) to chromosome region 8p22-p23.1. (1997) (130)
Autosomal Dominant Lateral Temporal Epilepsy: Clinical Spectrum, New Epitempin Mutations, and Genetic Heterogeneity in Seven European Families (2003) (129)
Follicular lymphoma lacking the t(14;18)(q32;q21): identification of two disease subtypes (2003) (129)
Germline and somatic FGFR1 abnormalities in dysembryoplastic neuroepithelial tumors (2016) (128)
The mutational pattern of primary lymphoma of the central nervous system determined by whole-exome sequencing (2014) (127)
A B-cell epigenetic signature defines three biologic subgroups of chronic lymphocytic leukemia with clinical impact (2014) (126)
Prognostic Significance of MYC Rearrangement and Translocation Partner in Diffuse Large B-Cell Lymphoma: A Study by the Lunenburg Lymphoma Biomarker Consortium. (2019) (123)
Pediatric-type nodal follicular lymphoma: an indolent clonal proliferation in children and adults with high proliferation index and no BCL2 rearrangement. (2012) (123)
DNA methylome analysis in Burkitt and follicular lymphomas identifies differentially methylated regions linked to somatic mutation and transcriptional control (2015) (120)
The Human Retinoblastoma Gene Is Imprinted (2009) (119)
Disruption of the BCL11B gene through inv(14)(q11.2q32.31) results in the expression of BCL11B-TRDC fusion transcripts and is associated with the absence of wild-type BCL11B transcripts in T-ALL (2005) (119)
The novel EPTP repeat defines a superfamily of proteins implicated in epileptic disorders. (2002) (119)
Molecular profiling of pediatric mature B-cell lymphoma treated in population-based prospective clinical trials. (2008) (118)
Poorly differentiated chordoma with SMARCB1/INI1 loss: a distinct molecular entity with dismal prognosis (2016) (114)
Follicular Lymphomas in Children and Young Adults: A Comparison of the Pediatric Variant With Usual Follicular Lymphoma (2013) (114)
Gray zone lymphoma: chromosomal aberrations with immunophenotypic and clinical correlations (2011) (113)
A deep learning system accurately classifies primary and metastatic cancers using passenger mutation patterns (2020) (113)
The different epidemiologic subtypes of Burkitt lymphoma share a homogenous micro RNA profile distinct from diffuse large B-cell lymphoma (2011) (113)
Classical and Molecular Cytogenetics of Tumor Cells (1999) (112)
Frequent occurrence of BCL6 rearrangements in nodular lymphocyte predominance Hodgkin lymphoma but not in classical Hodgkin lymphoma. (2003) (111)
The gray zone between Burkitt's lymphoma and diffuse large B-cell lymphoma from a genetics perspective. (2011) (109)
Whole-epigenome analysis in multiple myeloma reveals DNA hypermethylation of B cell-specific enhancers (2015) (109)
Expression profile of human defensins and antimicrobial proteins in oral tissues. (2001) (107)
Pediatric follicular lymphoma – a clinico-pathological study of a population-based series of patients treated within the Non-Hodgkin’s Lymphoma - Berlin-Frankfurt-Münster (NHL-BFM) multicenter trials (2010) (105)
Epigenetic Signatures Associated with Different Levels of Differentiation Potential in Human Stem Cells (2009) (105)
Detection of genomic imbalances in microdissected Hodgkin and Reed-Sternberg cells of classical Hodgkin’s lymphoma by array-based comparative genomic hybridization (2008) (104)
Loss of a novel tumor suppressor gene locus at chromosome 8p is associated with leukemic mantle cell lymphoma. (2001) (102)
Interphase FISH assays for the detection of translocations with breakpoints in immunoglobulin light chain loci (2002) (101)
ALK-positive anaplastic large cell lymphoma limited to the skin: clinical, histopathological and molecular analysis of 6 pediatric cases. A report from the ALCL99 study (2013) (99)
Molecular cytogenetic analysis of chromosomal breakpoints in the IGH, MYC, BCL6, and MALT1 gene loci in primary cutaneous B-cell lymphomas. (2004) (99)
Molecular analysis of single B cells from T-cell-rich B-cell lymphoma shows the derivation of the tumor cells from mutating germinal center B cells and exemplifies means by which immunoglobulin genes are modified in germinal center B cells. (1999) (96)
Clinical and molecular features in patients with atypical teratoid rhabdoid tumor or malignant rhabdoid tumor (2010) (96)
A chromosomal translocation in cyclin D1-negative/cyclin D2-positive mantle cell lymphoma fuses the CCND2 gene to the IGK locus. (2006) (96)
A 3‐cM commonly deleted region in 6q21 in leukemias and lymphomas delineated by fluorescence in situ hybridization (2000) (95)
Molecular analysis of the CALM/AF10 fusion: identical rearrangements in acute myeloid leukemia, acute lymphoblastic leukemia and malignant lymphoma patients (2000) (94)
A comprehensive genetic and histopathologic analysis identifies two subgroups of B-cell malignancies carrying a t(14;19)(q32;q13) or variant BCL3-translocation (2007) (94)
Deletions in 16p13 including GRIN2A in patients with intellectual disability, various dysmorphic features, and seizure disorders of the rolandic region (2010) (94)
Genomic Alterations in CIITA Are Frequent in Primary Mediastinal Large B Cell Lymphoma and Are Associated with Diminished MHC Class II Expression. (2015) (92)
MINCR is a MYC-induced lncRNA able to modulate MYC’s transcriptional network in Burkitt lymphoma cells (2015) (92)
Clinicopathologic correlations of genomic gains and losses in follicular lymphoma. (2002) (91)
Decoding the DNA Methylome of Mantle Cell Lymphoma in the Light of the Entire B Cell Lineage. (2016) (91)
MYC/MIZ1-dependent gene repression inversely coordinates the circadian clock with cell cycle and proliferation (2016) (90)
CD95 and TRAF2 promote invasiveness of pancreatic cancer cells (2005) (90)
Maternal variants in NLRP and other maternal effect proteins are associated with multilocus imprinting disturbance in offspring (2018) (90)
Multicolor-FICTION: expanding the possibilities of combined morphologic, immunophenotypic, and genetic single cell analyses. (2002) (89)
Molecular‐cytogenetic comparison of mucosa‐associated marginal zone B‐cell lymphoma and large B‐cell lymphoma arising in the gastro‐intestinal tract (2001) (87)
Genetic lesions of the TRAF3 and MAP3K14 genes in classical Hodgkin lymphoma (2012) (87)
B-cell-specific conditional expression of Myd88p.L252P leads to the development of diffuse large B-cell lymphoma in mice. (2016) (86)
Combined single nucleotide polymorphism-based genomic mapping and global gene expression profiling identifies novel chromosomal imbalances, mechanisms and candidate genes important in the pathogenesis of T-cell prolymphocytic leukemia with inv(14)(q11q32) (2007) (86)
Cribriform Neuroepithelial Tumor (CRINET): A Nonrhabdoid Ventricular Tumor With INI1 Loss and Relatively Favorable Prognosis (2009) (86)
eFORGE: A Tool for Identifying Cell Type-Specific Signal in Epigenomic Data (2016) (86)
Analysis of short tandem repeat expansions and their methylation state with nanopore sequencing (2019) (86)
Distinct DNA methylation patterns in cirrhotic liver and hepatocellular carcinoma (2012) (86)
Mutations of CARD11 but not TNFAIP3 may activate the NF-κB pathway in primary CNS lymphoma (2010) (85)
Eμ/miR-125b transgenic mice develop lethal B-cell malignancies (2011) (85)
Deletion of chromosome 11q predicts response to anthracycline-based chemotherapy in early breast cancer. (2007) (85)
Mutations of NFKBIA, encoding IκBα, are a recurrent finding in classical Hodgkin lymphoma but are not a unifying feature of non‐EBV‐associated cases (2009) (82)
DNA Methylation Profiles and Their Relationship with Cytogenetic Status in Adult Acute Myeloid Leukemia (2010) (82)
Genomic and epigenomic insights into the origin, pathogenesis and clinical behavior of mantle cell lymphoma subtypes. (2020) (82)
Aberrant expression of ID2, a suppressor of B-cell-specific gene expression, in Hodgkin's lymphoma. (2006) (81)
Genomic and transcriptomic changes complement each other in the pathogenesis of sporadic Burkitt lymphoma (2019) (81)
ST18 is a breast cancer tumor suppressor gene at human chromosome 8q11.2 (2004) (81)
Clinicopathogenetic significance of chromosomal abnormalities in patients with blastic peripheral B-cell lymphoma. Kiel-Wien-Lymphoma Study Group. (1999) (80)
The NFATc1 transcription factor is widely expressed in white cells and translocates from the cytoplasm to the nucleus in a subset of human lymphomas (2005) (80)
Changes of bivalent chromatin coincide with increased expression of developmental genes in cancer (2016) (80)
Chromosomal breakpoints affecting immunoglobulin loci are recurrent in Hodgkin and Reed-Sternberg cells of classical Hodgkin lymphoma. (2006) (79)
Clinical, pathological and genetic features of primary mediastinal large B-cell lymphomas and mediastinal gray zone lymphomas in children (2011) (79)
Mechismo: predicting the mechanistic impact of mutations and modifications on molecular interactions (2014) (78)
Microarray‐based genomic profiling reveals novel genomic aberrations in follicular lymphoma which associate with patient survival and gene expression status (2009) (77)
Clinical and morphologic features of B-cell small lymphocytic lymphoma with del(6)(q21q23). (1994) (77)
Four patients with speech delay, seizures and variable corpus callosum thickness sharing a 0.440 Mb deletion in region 1q44 containing the HNRPU gene. (2010) (76)
Timing the initiation of multiple myeloma (2019) (76)
Detection of genomic aberrations in molecularly defined Burkitt’s lymphoma by array-based, high resolution, single nucleotide polymorphism analysis (2010) (76)
Incidence and prognostic impact of secondary cytogenetic aberrations in a series of 145 patients with mantle cell lymphoma (2010) (75)
Recurrent mutation of JAK3 in T‐cell prolymphocytic leukemia (2014) (75)
Chromosomal rearrangements involving the BCL3 locus are recurrent in classical Hodgkin and peripheral T-cell lymphoma. (2006) (75)
Minimal residual disease detection in mantle cell lymphoma: methods and significance of four-color flow cytometry compared to consensus IGH-polymerase chain reaction at initial staging and for follow-up examinations (2008) (73)
Expression of MALT1 oncogene in hematopoietic stem/progenitor cells recapitulates the pathogenesis of human lymphoma in mice (2012) (72)
Hunting for the 5th base: Techniques for analyzing DNA methylation. (2009) (72)
Downregulation of the TGFβ Pseudoreceptor BAMBI in Non-Small Cell Lung Cancer Enhances TGFβ Signaling and Invasion. (2016) (72)
Clinical features of maternal uniparental disomy 14 in patients with an epimutation and a deletion of the imprinted DLK1/GTL2 gene cluster (2008) (72)
Silver‐Russell patients showing a broad range of ICR1 and ICR2 hypomethylation in different tissues (2011) (70)
Gains of REL in primary mediastinal B‐cell lymphoma coincide with nuclear accumulation of REL protein (2007) (70)
Primary lymphoma of the central nervous system: just DLBCL or not? (2009) (70)
Lymphoma stem cells: enough evidence to support their existence? (2010) (70)
Interphase Cytogenetic Analysis of Lymphoma‐Associated Chromosomal Breakpoints in Primary Diffuse Large B‐Cell Lymphomas of the Central Nervous System (2002) (69)
Chromosomal aberration patterns differ in subtypes of primary cutaneous B cell lymphomas. (2004) (68)
Chromosomal imbalances and partial uniparental disomies in primary central nervous system lymphoma (2009) (67)
Frequent deletions of 6q23–24 in B‐cell non‐Hodgkin's lymphomas detected by fluorescence in situ hybridization (1997) (67)
Cyclin D 1 – negative mantle cell lymphoma : a clinicopathologic study based on gene expression profiling (2005) (67)
High resolution ArrayCGH and expression profiling identifies PTPRD and PCDH17/PCH68 as tumor suppressor gene candidates in laryngeal squamous cell carcinoma (2011) (66)
High expression of several tyrosine kinases and activation of the PI3K/AKT pathway in mediastinal large B cell lymphoma reveals further similarities to Hodgkin lymphoma (2007) (66)
t(6;14)(p22;q32): a new recurrent IGH@ translocation involving ID4 in B-cell precursor acute lymphoblastic leukemia (BCP-ALL). (2008) (65)
The DNA sequence and comparative analysis of human chromosome 10 (2004) (65)
Application of interphase fluorescence in situ Hybridization for the detection of the Burkitt translocation t(8;14)(q24;q32) in B-cell lymphomas. (1998) (65)
Hypermutation of the Inactive X Chromosome Is a Frequent Event in Cancer (2013) (64)
Frequent triple-hit expression of MYC, BCL2, and BCL6 in primary lymphoma of the central nervous system and absence of a favorable MYClowBCL2low subgroup may underlie the inferior prognosis as compared to systemic diffuse large B cell lymphomas (2013) (64)
Increasing genomic and epigenomic complexity in the clonal evolution from in situ to manifest t(14;18)-positive follicular lymphoma (2014) (64)
Identification of overexpressed genes in frequently gained/amplified chromosome regions in multiple myeloma. (2006) (64)
Molecular cytogenetic detection of chromosomal breakpoints in T-cell receptor gene loci (2003) (64)
Hematopoietic stem cell involvement in BCR-ABL1-positive ALL as a potential mechanism of resistance to blinatumomab therapy. (2017) (63)
Gains of the proto-oncogene BCL11A and nuclear accumulation of BCL11AXL protein are frequent in primary mediastinal B-cell lymphoma (2006) (61)
Molecular features of B-cell lymphoma (2001) (61)
Non‐linkage of familial rhabdoid tumors to SMARCB1 implies a second locus for the rhabdoid tumor predisposition syndrome (2006) (61)
Improved 6‐year overall survival in AT/RT – results of the registry study Rhabdoid 2007 (2016) (61)
Genes encoding members of the JAK‐STAT pathway or epigenetic regulators are recurrently mutated in T‐cell prolymphocytic leukaemia (2016) (60)
TP53 mutation and survival in aggressive B cell lymphoma (2017) (60)
Strong BCL10 nuclear expression identifies gastric MALT lymphomas that do not respond to H pylori eradication (2005) (60)
Genes regulating the B cell receptor pathway are recurrently mutated in primary central nervous system lymphoma (2012) (59)
Integrative genomic analysis identifies key pathogenic mechanisms in primary mediastinal large B-cell lymphoma. (2019) (59)
Recurrent RHOA mutations in pediatric Burkitt lymphoma treated according to the NHL‐BFM protocols (2014) (58)
Systems biology of primary CNS lymphoma: from genetic aberrations to modeling in mice (2014) (58)
A cyclin-D1 interaction with BAX underlies its oncogenic role and potential as a therapeutic target in mantle cell lymphoma (2011) (58)
Genomic and epigenomic co-evolution in follicular lymphomas (2014) (58)
Immunoglobulin heavy chain locus chromosomal translocations in B-cell precursor acute lymphoblastic leukemia: rare clinical curios or potent genetic drivers? (2010) (57)
CCND2 and CCND3 hijack immunoglobulin light-chain enhancers in cyclin D1- mantle cell lymphoma. (2019) (57)
Epigenetic inactivation of the Groucho homologue gene TLE1 in hematologic malignancies. (2008) (57)
Identification of an AR Mutation-Negative Class of Androgen Insensitivity by Determining Endogenous AR Activity (2016) (56)
Recurrent Inactivation of the PRDM1 Gene in Primary Central Nervous System Lymphoma (2008) (56)
Folate-sensitive fragile site FRA10A is due to an expansion of a CGG repeat in a novel gene, FRA10AC1, encoding a nuclear protein. (2004) (56)
Defining the prognosis of early stage chronic lymphocytic leukaemia patients (2012) (55)
Application of interphase cytogenetics for the detection of t(11;14)(q13;q32) in mantle cell lymphomas. (1998) (55)
Chromosomal abnormalities in nodal and extranodal CD30+ anaplastic large cell lymphomas: Infrequent detection of the t(2;5) in extranodal lymphomas (1998) (55)
Recurrent loss of heterozygosity in 1p36 associated with TNFRSF14 mutations in IRF4 translocation negative pediatric follicular lymphomas (2013) (55)
WHO ) classification of lymphoid neoplasms (2016) (54)
The B-cell receptor controls fitness of MYC-driven lymphoma cells via GSK3β inhibition (2017) (53)
Molecular cytogenetic analyses of immunoglobulin loci in nodular lymphocyte predominant Hodgkin's lymphoma reveal a recurrent IGH-BCL6 juxtaposition. (2005) (53)
Adult high-grade B-cell lymphoma with Burkitt lymphoma signature: genomic features and potential therapeutic targets. (2017) (53)
Distribution of NPM1‐ALK and X‐ALK fusion transcripts in paediatric anaplastic large cell lymphoma: a molecular–histological correlation (2009) (53)
Linkage and LOH studies in 19 cylindromatosis families show no evidence of genetic heterogeneity and refine the CYLD locus on chromosome 16q12–q13 (2000) (53)
Complex variant translocation t(1;2) with TPM3-ALK fusion due to cryptic ALK gene rearrangement in anaplastic large-cell lymphoma. (1999) (52)
Mutations in the genes coding for the NF-κB regulating factors IκBα and A20 are uncommon in nodular lymphocyte-predominant Hodgkin’s lymphoma (2010) (52)
High resolution SNP array genomic profiling of peripheral T cell lymphomas, not otherwise specified, identifies a subgroup with chromosomal aberrations affecting the REL locus (2010) (51)
Biallelic inactivation of TRAF3 in a subset of B-cell lymphomas with interstitial del(14)(q24.1q32.33) (2009) (51)
Epigenetic Activation of SOX11 in Lymphoid Neoplasms by Histone Modifications (2011) (51)
Pathway activation patterns in diffuse large B-cell lymphomas (2008) (50)
Age and DNA-methylation subgroup as potential independent risk factors for treatment stratification in children with Atypical Teratoid/Rhabdoid Tumors (ATRT). (2019) (50)
Detection of translocations affecting the BCL6 locus in B cell non-Hodgkin's lymphoma by interphase fluorescence in situ hybridization (2001) (50)
Distinct comparative genomic hybridisation profiles in gastric mucosa‐associated lymphoid tissue lymphomas with and without t(11;18)(q21;q21) (2006) (50)
Loss of expression of LyGDI (ARHGDIB), a rho GDP‐dissociation inhibitor, in Hodgkin lymphoma * (2007) (48)
High-resolution architecture and partner genes of MYC rearrangements in lymphoma with DLBCL morphology. (2018) (48)
Interleukin-1 gene polymorphisms and experimental gingivitis. (2003) (48)
Central precocious puberty in girls with Williams syndrome. (2002) (48)
Chromosomal Translocations Fusing the BCL6 Gene to Different Partner Loci Are Recurrent in Primary Central Nervous System Lymphoma and May Be Associated With Aberrant Somatic Hypermutation or Defective Class Switch Recombination (2006) (47)
B-cell receptor-driven MALT1 activity regulates MYC signaling in mantle cell lymphoma. (2017) (47)
Segmental chromosomal aberrations and centrosome amplifications: pathogenetic mechanisms in Hodgkin and Reed–Sternberg cells of classical Hodgkin's lymphoma? (2003) (47)
Interphase cytogenetics of hematological neoplasms under the perspective of the novel WHO classification. (2003) (47)
Mapping of transcription factor motifs in active chromatin identifies IRF5 as key regulator in classical Hodgkin lymphoma (2014) (47)
Amplification of IGH/MYC fusion in clinically aggressive IGH/BCL2‐positive germinal center B‐cell lymphomas (2005) (46)
SAMHD1 is recurrently mutated in T-cell prolymphocytic leukemia (2018) (46)
The BCL 11 gene family : involvement of BCL 11 A in lymphoid malignancies (2001) (45)
Familial Williams-Beuren syndrome showing varying clinical expression. (2001) (45)
Role of the cyclin-dependent kinase 4 and 6 inhibitor gene family p15, p16, p18 and p19 in leukemia and lymphoma. (1996) (45)
Cribriform neuroepithelial tumor: molecular characterization of a SMARCB1‐deficient non‐rhabdoid tumor with favorable long‐term outcome (2017) (45)
Identification of PML as novel PAX5 fusion partner in childhood acute lymphoblastic leukaemia (2007) (45)
Genetic Characteristics of the Human Hepatic Stellate Cell Line LX-2 (2013) (45)
The mutational landscape of Burkitt-like lymphoma with 11q aberration is distinct from that of Burkitt lymphoma. (2019) (45)
Additional molecular findings in 11p15-associated imprinting disorders: an urgent need for multi-locus testing (2014) (44)
FCGR3 variants and expression of human neutrophil antigen‐1a, ‐1b, and ‐1c in the populations of northern Germany and Uganda (2002) (44)
Transcriptional Profiling of the Nuclear Factor-&kgr;B Pathway Identifies a Subgroup of Primary Lymphoma of the Central Nervous System With Low BCL10 Expression (2007) (44)
Inhibition of Anaplastic Lymphoma Kinase (ALK) Activity Provides a Therapeutic Approach for CLTC-ALK-Positive Human Diffuse Large B Cell Lymphomas (2011) (43)
Relevance of ID3-TCF3-CCND3 pathway mutations in pediatric aggressive B-cell lymphoma treated according to the non-Hodgkin Lymphoma Berlin-Frankfurt-Münster protocols (2017) (43)
BCL2 expression in chronic lymphocytic leukemia: lack of association with the BCL2 938A>C promoter single nucleotide polymorphism. (2008) (43)
A Recurrent Germline Mutation in the 5’UTR of the Androgen Receptor Causes Complete Androgen Insensitivity by Activating Aberrant uORF Translation (2016) (42)
Technology-specific error signatures in the 1000 Genomes Project data (2011) (42)
Identification of candidate tumor‐suppressor genes in 6q27 by combined deletion mapping and electronic expression profiling in lymphoid neoplasms (2003) (42)
Rare occurrence of biallelic CYLD gene mutations in classical Hodgkin lymphoma (2010) (42)
A unique case of follicular lymphoma provides insights to the clonal evolution from follicular lymphoma in situ to manifest follicular lymphoma. (2011) (42)
Deregulation of the telomerase reverse transcriptase (TERT) gene by chromosomal translocations in B-cell malignancies. (2010) (42)
Similar clinical features in follicular lymphomas with and without breaks in the BCL2 locus (2016) (41)
Homogeneous immunophenotype and paucity of secondary genomic aberrations are distinctive features of endemic but not of sporadic Burkitt's lymphoma and diffuse large B‐cell lymphoma with MYC rearrangement (2004) (41)
Partial uniparental disomy: a recurrent genetic mechanism alternative to chromosomal deletion in malignant lymphoma (2006) (41)
Genomic profiling of Acute lymphoblastic leukemia in ataxia telangiectasia patients reveals tight link between ATM mutations and chromothripsis (2017) (41)
Differential diagnosis of cyclin D2+ mantle cell lymphoma based on fluorescence in situ hybridization and quantitative real-time-PCR (2009) (41)
ALK-positive diffuse large B-cell lymphoma with ALK-Clathrin fusion belongs to the spectrum of pediatric lymphomas (2005) (41)
Gain of chromosome region 18q21 including the MALT1 gene is associated with the activated B-cell-like gene expression subtype and increased BCL2 gene dosage and protein expression in diffuse large B-cell lymphoma (2008) (40)
Trisomy 19 is associated with trisomy 12 and mutated IGHV genes in B‐chronic lymphocytic leukaemia (2007) (40)
Bullous sweet syndrome in a patient with t(9;22)(q34;q11)-positive chronic myeloid leukemia treated with the tyrosine kinase inhibitor nilotinib: interphase cytogenetic detection of BCR-ABL- positive lesional cells. (2008) (39)
Translocations activating IRF 4 identify a subtype of germinal center-derived B-cell lymphoma affecting predominantly children and young adults * (2011) (39)
Alterations of microRNA and microRNA-regulated messenger RNA expression in germinal center B-cell lymphomas determined by integrative sequencing analysis (2016) (39)
Identified hidden genomic changes in mantle cell lymphoma using high-resolution single nucleotide polymorphism genomic array. (2009) (39)
Homeobox NKX2-3 promotes marginal-zone lymphomagenesis by activating B-cell receptor signalling and shaping lymphocyte dynamics (2016) (38)
A Specific CNOT1 Mutation Results in a Novel Syndrome of Pancreatic Agenesis and Holoprosencephaly through Impaired Pancreatic and Neurological Development (2019) (38)
Array-based DNA methylation analysis in classical Hodgkin lymphoma reveals new insights into the mechanisms underlying silencing of B cell-specific genes (2012) (37)
Loss of protein expression and recurrent DNA hypermethylation of the GNG7 gene in squamous cell carcinoma of the head and neck (2011) (37)
Array-based DNA methylation profiling in male infertility reveals allele-specific DNA methylation in PIWIL1 and PIWIL2. (2014) (37)
Base-pair resolution DNA methylome of the EBV-positive Endemic Burkitt lymphoma cell line DAUDI determined by SOLiD bisulfite-sequencing (2013) (36)
ACEseq – allele specific copy number estimation from whole genome sequencing (2017) (36)
Androgen Receptor Function Links Human Sexual Dimorphism to DNA Methylation (2013) (36)
Homozygous and compound-heterozygous mutations in TGDS cause Catel-Manzke syndrome. (2014) (36)
Array-based DNA methylation profiling of primary lymphomas of the central nervous system (2009) (36)
Identification of candidate tumour suppressor gene loci for Hodgkin and Reed‐Sternberg cells by characterisation of homozygous deletions in classical Hodgkin lymphoma cell lines (2008) (36)
DNA-Methylation Profiling of Fetal Tissues Reveals Marked Epigenetic Differences between Chorionic and Amniotic Samples (2012) (36)
Sellar Region Atypical Teratoid/Rhabdoid Tumors (ATRT) in Adults Display DNA Methylation Profiles of the ATRT-MYC Subgroup (2018) (35)
The BCL6 gene in B-cell lymphomas with 3q27 translocations is expressed mainly from the rearranged allele irrespective of the partner gene (2003) (35)
Pyrosequencing-based DNA methylation profiling of Fanconi anemia/BRCA pathway genes in laryngeal squamous cell carcinoma. (2011) (35)
Rapid amplification of immunoglobulin heavy chain switch (IGHS) translocation breakpoints using long-distance inverse PCR (2004) (34)
R-CHOP/R-DHAP Compared to R-CHOP Induction Followed by High Dose Therapy with Autologous Stem Cell Transplantation Induces Higher Rates of Molecular Remission In MCL: Results of the MCL Younger Intergroup Trial of the European MCL Network (2010) (34)
High-coverage whole-genome analysis of 1220 cancers reveals hundreds of genes deregulated by rearrangement-mediated cis-regulatory alterations (2020) (34)
Epigenetic regulation of CD44 in Hodgkin and non-Hodgkin lymphoma (2010) (33)
Expression of the LGI1 gene product in astrocytic gliomas: downregulation with malignant progression (2003) (33)
Mutation of an IKK phosphorylation site within the transactivation domain of REL in two patients with B-cell lymphoma enhances REL's in vitro transforming activity (2007) (33)
A modular transcriptome map of mature B cell lymphomas (2019) (33)
Germline determinants of the somatic mutation landscape in 2,642 cancer genomes (2017) (33)
IG-MYC + neoplasms with precursor B-cell phenotype are molecularly distinct from Burkitt lymphomas. (2018) (32)
An Easy and Reliable Procedure of Microdissection Technique for the Analysis of Chromosomal Breakpoints and Marker Chromosomes (2004) (32)
Opposing Effects of CREBBP Mutations Govern the Phenotype of Rubinstein-Taybi Syndrome and Adult SHH Medulloblastoma. (2018) (32)
Sequential karyotyping in Burkitt lymphoma reveals a linear clonal evolution with increase in karyotype complexity and a high frequency of recurrent secondary aberrations (2015) (32)
Short telomeres and high telomerase activity in T-cell prolymphocytic leukemia (2007) (32)
GeneChip analyses point to novel pathogenetic mechanisms in mantle cell lymphoma (2009) (32)
A comprehensive flow-cytometry-based immunophenotypic characterization of Burkitt-like lymphoma with 11q aberration (2018) (32)
High frequency of the N34S mutation in the SPINK1 gene in chronic pancreatitis detected by a new PCR-RFLP assay. (2001) (32)
Family-based germline sequencing in children with cancer (2018) (31)
Functionally Null RAD51D Missense Mutation Associates Strongly with Ovarian Carcinoma. (2017) (31)
Multiple DICER1‐related tumors in a child with a large interstitial 14q32 deletion (2018) (31)
Recurrent alterations of TNFAIP3 (A20) in T‐cell large granular lymphocytic leukemia (2016) (31)
BCL6 alternative breakpoint region break and homozygous deletion of 17q24 in the nodular lymphocyte predominance type of Hodgkin's lymphoma-derived cell line DEV. (2006) (31)
Homozygous deletion of SOCS1 in primary mediastinal B-cell lymphoma detected by CGH to BAC microarrays (2005) (31)
B-SOLANA: an approach for the analysis of two-base encoding bisulfite sequencing data (2011) (31)
A de novo 0.57 Mb microdeletion in chromosome 11q13.1 in a patient with speech problems, autistic traits, dysmorphic features and multiple endocrine neoplasia type 1. (2011) (31)
Molecular Characterization of BCL6 Breakpoints in Primary Diffuse Large B‐cell Lymphomas of the Central Nervous System Identifies GAPD as Novel Translocation Partner (2003) (31)
Feasibility of Intensive Multimodal Therapy in Infants Affected by Rhabdoid Tumors – Experience of the EU-RHAB registry (2014) (31)
NOTCH1, TP53, and MAP2K1 Mutations in Splenic Diffuse Red Pulp Small B-cell Lymphoma Are Associated With Progressive Disease (2015) (30)
The BCR-ABL1 Kinase Bypasses Selection for the Expression of a Pre–B Cell Receptor in Pre–B Acute Lymphoblastic Leukemia Cells (2004) (30)
JAK/STAT-Activating Genomic Alterations Are a Hallmark of T-PLL (2019) (30)
Cancer initiation with epistatic interactions between driver and passenger mutations. (2013) (30)
Lack of somatic hypermutation of IG VH genes in lymphoid malignancies with t(2;14)(p13;q32) translocation involving the BCL11A gene (2002) (30)
Alterations of the CD58 gene in classical Hodgkin lymphoma (2015) (29)
Identification of ZCCHC8 as fusion partner of ROS1 in a case of congenital glioblastoma multiforme with a t(6;12)(q21;q24.3) (2016) (29)
CREBBP gene mutations are frequently detected in in situ follicular neoplasia. (2018) (29)
Genotype–phenotype correlation in eight new patients with a deletion encompassing 2q31.1 (2010) (29)
Characterization of genomic imbalances in diffuse large B‐cell lymphoma by detailed SNP‐chip analysis (2015) (29)
The PCBP1 gene encoding poly(rc) binding protein i is recurrently mutated in Burkitt lymphoma (2015) (29)
Recurrent deletions of the TNFSF7 and TNFSF9 genes in 19p13.3 in diffuse large B‐cell and Burkitt lymphomas (2012) (29)
Follicular lymphoma grade 3B. (2011) (28)
Homozygous loss of the MTSl/pl6 and MTS2/pl5 genes in lymphoma and lymphoblastic leukaemia cell lines (1995) (28)
Sigmoid diverticulitis in patients with Williams–Beuren syndrome: Relatively high prevalence and high complication rate in young adults with the syndrome (2005) (28)
Deep Bisulfite Sequencing of Aberrantly Methylated Loci in a Patient with Multiple Methylation Defects (2013) (28)
The BCR-ABL1 kinase bypasses selection for the expression of a pre-B cell receptor in pre-B acute lymphoblastic leukemia cells. (2004) (28)
High resolution copy number analysis of IRF4 translocation‐positive diffuse large B‐cell and follicular lymphomas (2013) (27)
A familial disorder of altered DNA-methylation (2014) (27)
Deletions in the Long Arm of Chromosome 10 in Lymphomas With t(14;18): A Pathogenetic Role of the Tumor Suppressor Genes PTEN/MMAC1 and MXI1? (1998) (27)
Genomic basis for RNA alterations revealed by whole-genome analyses of 27 cancer types (2017) (27)
Primary adenocarcinoma of the thymus: an immunohistochemical and molecular study with review of the literature (2013) (27)
BCL6 gene rearrangement and protein expression are associated with large cell presentation of extranodal marginal zone B‐cell lymphoma of mucosa‐associated lymphoid tissue (2011) (27)
Experience with provisional WHO‐entities large B‐cell lymphoma with IRF4‐rearrangement and Burkitt‐like lymphoma with 11q aberration in paediatric patients of the NHL‐BFM group (2020) (26)
Molecular characterization of acute lymphoblastic leukemia with high CRLF2 gene expression in childhood (2017) (26)
Array-based DNA methylation analysis in individuals with developmental delay/intellectual disability and normal molecular karyotype. (2015) (26)
Fluorescence in situ hybridization as a diagnostic tool in malignant lymphomas (1997) (26)
Breakpoint cloning and haplotype analysis indicate a single origin of the common Inv(10)(p11.2q21.2) mutation among northern Europeans. (2006) (26)
Cytogenetical assignment and physical mapping of the human R-PTP-kappa gene (PTPRK) to the putative tumor suppressor gene region 6q22.2-q22.3. (1998) (26)
No evidence for deletions of the NBS1 gene in lymphomas. (2001) (26)
Differences between BCL2-break positive and negative follicular lymphoma unraveled by whole-exome sequencing (2018) (26)
Disorders of sex development expose transcriptional autonomy of genetic sex and androgen-programmed hormonal sex in human blood leukocytes (2009) (25)
Phenotypic spectrum and extent of DNA methylation defects associated with multilocus imprinting disturbances. (2016) (25)
Desmoplastic myxoid tumor, SMARCB1-mutant: clinical, histopathological and molecular characterization of a pineal region tumor encountered in adolescents and adults (2019) (25)
An unbalanced translocation involving chromosome 14 is the probable cause for loss of potentially functional rearranged immunoglobulin heavy chain genes in the Epstein–Barr virus‐positive Hodgkin's lymphoma‐derived cell line L591 (2002) (25)
Characterization of 8 p 21 . 3 chromosomal deletions in B-cell lymphoma : TRAIL-R 1 and TRAIL-R 2 as candidate dosage-dependent tumor suppressor genes (2005) (25)
Aberrant DNA methylation of ADAMTS16 in colorectal and other epithelial cancers (2018) (25)
DNA methylation profiling of pediatric B‐cell lymphoblastic leukemia with KMT2A rearrangement identifies hypomethylation at enhancer sites (2017) (24)
Detection of deletions in the short arm of chromosome 3 in uncultured renal cell carcinomas by interphase cytogenetics. (1998) (24)
Recurrent loss, but lack of mutations, of the SMARCB1 tumor suppressor gene in T-cell prolymphocytic leukemia with TCL1A-TCRAD juxtaposition. (2009) (24)
Cell‐of‐origin classification by gene expression and MYC‐rearrangements in diffuse large B‐cell lymphoma of children and adolescents (2017) (24)
The pattern of genomic gains in salivary gland MALT lymphomas. (2007) (24)
A novel lymphoma-associated macrophage interaction signature (LAMIS) provides robust risk prognostication in diffuse large B-cell lymphoma clinical trial cohorts of the DSHNHL (2019) (24)
BCL2 and BCL3 are recurrent translocation partners of the IGH locus. (2008) (24)
Germline variants in SMARCB1 and other members of the BAF chromatin-remodeling complex across human disease entities: a meta-analysis (2018) (23)
X‐linked Dystonia‐Parkinsonism manifesting in a female patient due to atypical turner syndrome (2013) (23)
Characterization and chromosomal assignment of yeast artificial chromosomes containing human 3p13-p21-specific sequence tagged sites. (1995) (23)
Points-to-consider on the return of results in epigenetic research (2019) (23)
Signatures of mutational processes in human cancer this access benefits you. Your matters (2013) (23)
PVRL2 is translocated to the TRA@ locus in t(14;19)(q11;q13)‐positive peripheral T‐cell lymphomas (2007) (23)
Hypermethylation of the alternative AWT1 promoter in hematological malignancies is a highly specific marker for acute myeloid leukemias despite high expression levels (2014) (22)
Responses to the Selective Bruton’s Tyrosine Kinase (BTK) Inhibitor Tirabrutinib (ONO/GS-4059) in Diffuse Large B-cell Lymphoma Cell Lines (2018) (22)
Expression pattern of intracellular leukocyte-associated proteins in primary mediastinal B cell lymphoma (2005) (22)
Detection of chromothripsis‐like patterns with a custom array platform for chronic lymphocytic leukemia (2015) (22)
Inv(11)(q21q23) fuses MLL to the Notch co-activator mastermind-like 2 in secondary T-cell acute lymphoblastic leukemia (2008) (22)
Absence of simian virus 40 DNA sequences in primary central nervous system lymphoma in HIV-negative patients (2004) (22)
Mutational mechanisms shaping the coding and noncoding genome of germinal center derived B-cell lymphomas (2021) (22)
Clinical utility gene card for: Transient Neonatal Diabetes Mellitus, 6q24-related (2014) (22)
Improved classification of leukemic B-cell lymphoproliferative disorders using a transcriptional and genetic classifier (2017) (22)
Chromosome aberrations are restricted to the CD56+, CD3− tumour cell population in natural killer cell lymphomas: a combined immunophenotyping and FISH study (1999) (22)
Author Correction: The landscape of genomic alterations across childhood cancers (2018) (21)
The CBFA2T3/ACSF3 locus is recurrently involved in IGH chromosomal translocation t(14;16)(q32;q24) in pediatric B‐cell lymphoma with germinal center phenotype (2012) (21)
HHV-8-unrelated primary effusion-like lymphoma associated with clonal loss of inherited chromosomally-integrated human herpesvirus-6A from the telomere of chromosome 19q (2016) (21)
Statistical inference of allelic imbalance from transcriptome data (2011) (21)
Analysis of mutational signatures in exomes from B-cell lymphoma cell lines suggest APOBEC3 family members to be involved in the pathogenesis of primary effusion lymphoma (2015) (20)
Common clonal T‐cell origin in a patient with T‐prolymphocytic leukaemia and associated cutaneous T‐cell lymphomas (2003) (20)
Cryptic insertion of MYC exons 2 and 3 into the immunoglobulin heavy chain locus detected by whole genome sequencing in a case of “MYC-negative” Burkitt lymphoma (2020) (20)
MYC expression and translocation analyses in low‐grade and transformed follicular lymphoma (2017) (20)
Identification of the gene encoding cyclin E1 (CCNE1) as a novel IGH translocation partner in t(14;19)(q32;q12) in diffuse large B-cell lymphoma (2009) (20)
A maternal deletion upstream of the imprint control region 2 in 11p15 causes loss of methylation and familial Beckwith–Wiedemann syndrome (2016) (20)
Mesenchymal Hamartoma of the Liver and DICER1 Syndrome (2019) (20)
Advanced patient age at diagnosis of diffuse large B-cell lymphoma is associated with molecular characteristics including ABC-subtype and high expression of MYC (2018) (20)
Clinical and pathological features of Burkitt lymphoma showing expression of BCL2 – an analysis including gene expression in formalin‐fixed paraffin‐embedded tissue (2015) (19)
Centrosome abnormalities in ALK-positive anaplastic large-cell lymphoma (2004) (19)
Recurrent loss of the Y chromosome and homozygous deletions within the pseudoautosomal region 1: association with male predominance in mantle cell lymphoma (2008) (19)
Detection of secondary genetic aberrations in follicle center cell derived lymphomas: assessment of the reliability of comparative genomic hybridization and standard chromosome analysis (2001) (19)
Epigenome data release: a participant-centered approach to privacy protection (2015) (19)
Deletion of Chromosome 11 q Predicts Response to Anthracycline-Based Chemotherapy in Early Breast Cancer (2007) (18)
Gene dosage effects in chronic lymphocytic leukemia. (2010) (18)
DiGeorge syndrome with discordant phenotype in monozygotic twins (2000) (18)
Characterization of c-Maf transcription factor in normal and neoplastic hematolymphoid tissue and its relevance in plasma cell neoplasia. (2009) (18)
A 1 Mb-sized microdeletion Xq26.2 encompassing the GPC3 gene in a fetus with Simpson-Golabi-Behmel syndrome Report, antenatal findings and review. (2011) (17)
Low‐grade and high‐grade mammary carcinomas in WAP‐T transgenic mice are independent entities distinguished by Met expression (2013) (17)
Characterization of homozygous deletions in laryngeal squamous cell carcinoma cell lines. (2008) (17)
Unfavourable prognosis of patients with trisomy 18q21 detected by fluorescence in situ hybridisation in t(11;18) negative, surgically resected, gastrointestinal B cell lymphomas (2004) (17)
Cyclin D 3 is a target gene of t ( 6 ; 14 ) ( p 21 . 1 ; q 32 . 3 ) of mature B-cell malignancies (2001) (17)
DGCR8 microprocessor defect characterizes familial multinodular goiter with schwannomatosis. (2019) (17)
Hodgkin-Reed-Sternberg Cells in Classical Hodgkin Lymphoma Show Alterations of Genes Encoding the NADPH Oxidase Complex and Impaired Reactive Oxygen Species Synthesis Capacity (2013) (17)
Molecular switch from MYC to MYCN expression in MYC protein negative Burkitt lymphoma cases (2019) (17)
Genomic Abnormalities Acquired in the Blastic Transformation of Splenic Marginal Zone B-cell Lymphoma (2003) (17)
Combining array‐based approaches for the identification of candidate tumor suppressor loci in mature lymphoid neoplasms (2007) (17)
Integration of amplified BCR/ABL fusion genes into the short arm of chromosome 17 as a novel mechanism of disease progression in chronic myeloid leukemia (2001) (17)
Pan-cancer study of heterogeneous RNA aberrations (2017) (16)
SPAG7 is a candidate gene for the periodic fever, aphthous stomatitis, pharyngitis and adenopathy (PFAPA) syndrome (2014) (16)
SLP65 deficiency results in perpetual V(D)J recombinase activity in pre-B-lymphoblastic leukemia and B-cell lymphoma cells (2006) (16)
The differentially methylated region of MEG8 is hypermethylated in patients with Temple syndrome. (2015) (16)
Complete or partial trisomy 3 in gastro-intestinal MALT lymphomas co-occurs with aberrations at 18q21 and correlates with advanced disease stage: a study on 25 cases. (2005) (16)
A de novo 1.1Mb microdeletion of chromosome 19p13.11 provides indirect evidence for EPS15L1 to be a strong candidate for split hand split foot malformation. (2011) (16)
Chromosome 18 replaced by two ring chromosomes of chromosome 18 origin (2003) (15)
Detection of 6q deletions in breast carcinoma cell lines by fluorescence in situ hybridization (1998) (15)
Morphological variability of lymphohistiocytic variant of anaplastic large cell lymphoma (former lymphohistiocytic lymphoma according to the Kiel classification) (2008) (15)
Epigenetic Repression of Androgen Receptor Transcription in Mutation-Negative Androgen Insensitivity Syndrome (AIS Type II) (2018) (15)
Synchronous congenital malignant rhabdoid tumor of the orbit and atypical teratoid/rhabdoid tumor--feasibility and efficacy of multimodal therapy in a long-term survivor. (2014) (15)
Chromosomal abnormalities clustering in multiple myeloma reveals cytogenetic subgroups with nonrandom acquisition of chromosomal changes (2004) (15)
Author Correction: Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes (2018) (15)
Frequency and characterization of DNA methylation defects in children born SGA (2012) (14)
Cloning and localization of C2orf2(ropp120), a previously unknown WD repeat protein. (2000) (14)
Feasibility of simultaneous fluorescence immunophenotyping and fluorescence in situ hybridization study for the detection of estrogen receptor expression and deletions of the estrogen receptor gene in breast carcinoma cell lines (2000) (14)
TP53 codon 72 polymorphism in patients with chronic lymphocytic leukaemia: identification of a subgroup with mutated IGHV genes and poor clinical outcome (2011) (14)
Genetic instability of 3p12-p21-specific microsatellite sequences in renal cell carcinoma. (1996) (14)
Cytogenetic and molecular characterization of a patient with simultaneous B‐cell chronic lymphocytic leukemia and peripheral T‐cell lymphoma (2001) (14)
Amplification of ERBB2, RARA, and TOP2A genes in a myelodysplastic syndrome transforming to acute myeloid leukemia. (2001) (14)
The variant inv(2)(p11.2q13) is a genuinely recurrent rearrangement but displays some breakpoint heterogeneity. (2007) (14)
conditional expression of Myd 88 ( p . L 252 P ) leads to the development of diffuse large B cell lymphoma in mice (2017) (13)
A duplication in 1q21.3 in a family with early onset and childhood absence epilepsy (2010) (13)
Identification of recurrent chromosomal breakpoints in multiple myeloma with complex karyotypes by combined G-banding, spectral karyotyping, and fluorescence in situ hybridization analyses. (2006) (13)
Extramedullary manifestation of a donor-derived acute myeloid leukemia in a liver transplant patient (2004) (13)
Familial Hodgkin's and non-Hodgkin's lymphoma: different patterns in first-degree relatives. (1997) (13)
Corrigendum: Signatures of mutational processes in human cancer (2013) (13)
A Diagnostic Approach to the Identification of Burkitt-like Lymphoma With 11q Aberration in Aggressive B-Cell Lymphomas. (2020) (13)
Somatic mutations altering Tyr641 of EZH2 are rare in primary central nervous system lymphoma (2010) (12)
Report of a workshop on malignant lymphoma: a review of molecular and clinical risk profiling (2008) (12)
Integrative analysis of genomic variants reveals new associations of candidate haploinsufficient genes with congenital heart disease (2020) (12)
Jumping translocation of 1q as the sole aberration in a case of follicular lymphoma. (1999) (12)
Microarray‐based DNA methylation analysis of imprinted loci in a patient with transient neonatal diabetes mellitus (2008) (12)
Androgen Receptor Mutations Are Associated with Altered Epigenomic Programming as Evidenced by HOXA5 Methylation (2011) (12)
Pipeline for Large-Scale Microdroplet Bisulfite PCR-Based Sequencing Allows the Tracking of Hepitype Evolution in Tumors (2011) (12)
The PRDX2 gene is transcriptionally silenced and de novo methylated in Hodgkin and Reed-Sternberg cells of classical Hodgkin lymphoma. (2014) (12)
Molecular Remission after Combined Immunochemotherapy Is of Prognostic Relevance in Patients with MCL: Results of the Randomized Intergroup Trials of the European MCL Network (2008) (12)
Detection of translocations involving the HOX11/TCL3-locus in 10q24 by interphase fluorescence in situ hybridization. (2001) (11)
Mature B‐ and T‐cell neoplasms and Hodgkin lymphoma (2010) (11)
The extraordinary challenge of treating patients with congenital rhabdoid tumors—a collaborative European effort (2018) (11)
Inactivation of the putative ubiquitin-E3 ligase PDLIM2 in classical Hodgkin and anaplastic large cell lymphoma (2016) (11)
Mutation detection and physical mapping of the CD11 gene cluster in association with inflammatory bowel disease (2002) (11)
Transcription factor RFX7 governs a tumor suppressor network in response to p53 and stress (2021) (11)
Clinical and genetic risk factors define two risk groups of extracranial malignant rhabdoid tumours (eMRT/RTK). (2020) (10)
Evidence for gene recombination in FCGR3 gene variants (2009) (10)
The SRC family kinase LYN redirects B cell receptor signaling in human SLP65-deficient B cell lymphoma cells (2006) (10)
DNA methylation profiling allows for characterization of atrial and ventricular cardiac tissues and hiPSC-CMs (2019) (10)
Familial acute myeloid leukemia and DiGuglielmo syndrome. (1995) (10)
Epstein–Barr virus status of sporadic Burkitt lymphoma is associated with patient age and mutational features (2021) (10)
Mosaic genome-wide maternal isodiploidy: an extreme form of imprinting disorder presenting as prenatal diagnostic challenge (2017) (10)
Pulmonary mucosa-associated lymphoid tissue lymphoma with strong nuclear B-cell CLL/lymphoma 10 (BCL10) expression and novel translocation t(1;2)(p22;p12)/immunoglobulin κ chain-BCL10 (2006) (10)
Preferential Expression of Truncated Isoforms of FOXP1 in Primary Central Nervous System Lymphoma (2009) (10)
ETS1 encoding a transcription factor involved in B-cell differentiation is recurrently deleted and down-regulated in classical Hodgkin's lymphoma (2012) (10)
BCL10 gene amplification associated with strong nuclear BCL10 expression in a diffuse large B cell lymphoma with IGH-BCL2 fusion. (2006) (9)
Identification and characterization of a novel human brain-specific gene, homologous to S. scrofa tmp83.5, in the chromosome 10q24 critical region for temporal lobe epilepsy and spastic paraplegia. (2002) (9)
Endobronchial ALK+ Anaplastic Large-cell Lymphoma Resembling Asthma in a 13-Year-Old Girl (2013) (9)
MDM4 Is Targeted by 1q Gain and Drives Disease in Burkitt Lymphoma. (2019) (9)
Identifying molecular markers for the sensitive detection of residual atypical teratoid rhabdoid tumor cells. (2014) (9)
Recurrent chromosomal and epigenetic alterations in oral squamous cell carcinoma and its putative premalignant condition oral lichen planus (2019) (9)
Brief report t ( 6 ; 14 ) ( p 22 ; q 32 ) : a new recurrent IGH @ translocation involving ID 4 in B-cell precursor acute lymphoblastic leukemia ( BCP-ALL ) (2007) (9)
A girl with an atypical form of ataxia telangiectasia and an additional de novo 3.14 Mb microduplication in region 19q12. (2012) (9)
Novel IGH and MYC Translocation Partners in Diffuse Large B‐Cell Lymphomas (2016) (9)
Eosinophilic cellulitis as a presenting feature of chronic eosinophilic leukaemia, secondary to a deletion on chromosome 4q12 creating the FIP1L1–PDGFRA fusion gene (2006) (9)
Bi-allelic loss-of-function variants in KIF21A cause severe fetal akinesia with arthrogryposis multiplex (2021) (9)
A novel fusion of the MALT1 gene and the microtubule‐associated protein 4 (MAP4) gene occurs in diffuse large B‐cell lymphoma (2006) (9)
Reconstruction of rearranged T‐cell receptor loci by whole genome and transcriptome sequencing gives insights into the initial steps of T‐cell prolymphocytic leukemia (2020) (9)
Breakpoint characterization of the der(19)t(11;19)(q13;p13) in the ovarian cancer cell line SKOV‐3 (2013) (9)
Expression of ELF1, a lymphoid ETS domain‐containing transcription factor, is recurrently lost in classical Hodgkin lymphoma (2019) (8)
Multicolor interphase cytogenetics for the study of plasma cell dyscrasias. (2007) (8)
Mechanisms of intracerebral lymphoma growth delineated in a syngeneic mouse model of central nervous system lymphoma. (2013) (8)
How to analyse epigenetic marks? (2011) (8)
Clinical relevance of molecular characteristics in Burkitt lymphoma differs according to age (2022) (8)
Atypical teratoid/rhabdoid tumor arising in a malignant glioma (2017) (8)
The tissue is the issue: improved methylome analysis from paraffin-embedded tissues by application of the HOPE technique (2014) (8)
RBFOX2 and alternative splicing in B-cell lymphoma (2018) (8)
Burkitt's Lymphoma of the Stomach: a Case Report with Molecular Cytogenetic Analysis (2004) (8)
The genetic landscape of choroid plexus tumors in children and adults. (2020) (8)
DNA methylation profiling of hepatosplenic T-cell lymphoma (2018) (8)
Construction of a consistent YAC contig for human chromosome region 3p14.1. (1996) (8)
Anti-ALK Antibodies in Patients with ALK-Positive Malignancies Not Expressing NPM-ALK (2016) (8)
A Double Hit CD10-Negative B-Cell Lymphoma with t(3;8)(q27;q24) Leading to Juxtaposition of the BCL6 and MYC Loci Associated with Good Clinical Outcome (2014) (8)
Towards defining the lymphoma methylome (2006) (8)
Peripheral T-cell lymphoma with t(6;14)(p25;q11.2) translocation presenting with massive splenomegaly (2014) (8)
Genome-wide methylation analysis of retrocopy-associated CpG islands and their genomic environment (2016) (7)
Lack of deletions of the PTEN/MMAC1 and MXI1 loci in renal cell carcinoma by interphase cytogenetics. (2000) (7)
Characterization of two supernumerary marker chromosomes in a patient with signs of Klinefelter syndrome, mild facial anomalies, and severe speech delay * (2006) (7)
CDKN2A-Mutated Pancreatic Ductal Organoids from Induced Pluripotent Stem Cells to Model a Cancer Predisposition Syndrome (2021) (7)
PNMZL and PTFL: morphological variants with a common molecular profile - a unifying hypothesis. (2022) (7)
Analysis of the novel cyclin-dependent kinase 4 and 6 inhibitor gene p18 in lymphoma and leukemia cell lines. (1996) (7)
Spinal cord atypical teratoid/rhabdoid tumors in children: Clinical, genetic, and outcome characteristics in a representative European cohort (2020) (7)
ATYPICAL TERATOID RHABDOID TUMOR (ATRT) (2012) (7)
Primary Bilateral Burkitt Lymphoma of the Lactating Breast (2010) (7)
R-CHOP VS R-FC FOLLOWED BY MAINTENANCE WITH RITUXIMAB OR IFN: FIRST RESULTS OF MRD ASSESSMENT WITHIN THE RANDOMIZED TRIAL FOR ELDERLY PATIENTS WITH MCL (2011) (7)
A 2 Mb deletion in 14q13 associated with severe developmental delay and hemophagocytic lymphohistiocytosis. (2011) (7)
Primary bilateral Burkitt lymphoma of the lactating breast: a case report and review of the literature. (2010) (7)
Deletions in the long arm of chromosome 10 in lymphomas with t(14;18): a pathogenetic role of the tumor supressor genes PTEN/MMAC1 and MXI1? (1998) (7)
Guidelines and Quality Assurance for Acquired Cytogenetics A common European framework for quality assessment for banded chromosome studies and molecular cytogenetic investigations of acquired abnormalities (2013) (7)
Analysis of Driver Mutational Hot Spots in Blood-Derived Cell-Free DNA of Patients with Primary Central Nervous System Lymphoma Obtained before Intracerebral Biopsy. (2020) (7)
Mantle cell lymphomas with concomitant MYC and CCND1 breakpoints are recurrently TdT positive and frequently show high-grade pathological and genetic features (2021) (7)
Molecular characterization of a novel chromosomal translocation t(12;14)(q23;q11.2) in T‐lymphoblastic lymphoma between the T‐cell receptor delta‐deleting elements (TRDREC and TRAJ61) and the hypothetical gene C12orf42 (2010) (7)
Sequencing of t(2;7) translocations reveals a consistent breakpoint linking CDK6 to the IGK locus in indolent B-cell neoplasia. (2013) (7)
In vivo Investigations of the Effect of Short- and Long-Term Recombinant Growth Hormone Treatment on DNA-Methylation in Humans (2015) (7)
Introduction to a review series: the 2016 revision of the WHO classi ﬁ cation of tumors of hematopoietic and lymphoid tissues (2016) (7)
SAMHD 1 is recurrently mutated in T-cell prolymphocytic leukemia (7)
Further evidence that full gene deletions of DICER1 predispose to DICER1 syndrome (2019) (6)
Modified risk-stratified sequential treatment (subcutaneous rituximab with or without chemotherapy) in B-cell Post-transplant lymphoproliferative disorder (PTLD) after Solid organ transplantation (SOT): the prospective multicentre phase II PTLD-2 trial (2022) (6)
The t(11;14)(q13;q32)/CCND1-IGH translocation is a recurrent secondary genetic aberration in relapsed chronic lymphocytic leukemia (2016) (6)
Cytogenetic and molecular characterization of simultaneous chronic and acute myelocytic leukemia. (2003) (6)
Repeat expansion and methylation state analysis with nanopore sequencing (2018) (6)
Transient spontaneous remission in congenital MLL-AF10 rearranged acute myeloid leukemia presenting with cardiorespiratory failure and meconium ileus (2016) (6)
Frequent allelic loss of the BCL10 gene in lymphomas with the t(11;14)(q13;q32) (2001) (6)
A putative “hepitype” in the ATM gene associated with chronic lymphocytic leukemia risk (2011) (6)
Williams-Beuren syndrome 35 years after the diagnosis in one of the first Beuren patients. (2000) (6)
Pathogenic complexity of gastric B-cell lymphoma. (2002) (6)
Guidelines and Quality Assurance for Acquired Cytogenetics (2013) (6)
Studies of four new human myeloma cell lines (2005) (6)
How I approach hereditary cancer predisposition in a child with cancer (2019) (6)
The curious case of Merkel cell carcinoma: epigenetic youth and lack of pluripotency (2020) (6)
Massive Transcriptional Perturbation in Subgroups of Diffuse Large B-Cell Lymphomas (2013) (5)
Diffuse large B-cell lymphoma of Waldeyer's ring has distinct clinicopathologic features: a GELA study. (2012) (5)
Erratum: The NFATc1 transcription factor is widely expressed in white cells and translocates from the cytoplasm to the nucleus in a subset of human lymphomas (British Journal of Haematology (2005) 128 (333-342)) (2005) (5)
A 439 kb-sized homozygous deletion in 17p13.3 leading to biallelic loss of the ASPA as cause of Canavan disease detected by SNP-array analysis. (2010) (5)
FISH and FICTION to detect chromosomal aberrations in lymphomas. (2013) (5)
Rhabdoid Tumor Predisposition Syndrome (2020) (5)
Two molecularly distinct atypical teratoid/rhabdoid tumors (or tumor components) occurring in an infant with rhabdoid tumor predisposition syndrome 1 (2019) (5)
Non‐leukemic pediatric mixed phenotype acute leukemia/lymphoma: Genomic characterization and clinical outcome in a prospective trial for pediatric lymphoblastic lymphoma (2019) (5)
Complex and Dynamic Chromosomal Rearrangements in a Family With Seemingly Non-Mendelian Inheritance of Dopa-Responsive Dystonia (2017) (5)
Monomorphic epitheliotropic intestinal T-cell lymphoma comprises morphologic and genomic heterogeneity impacting outcome (2022) (5)
Enforced expression of MIR142, a target of chromosome translocation in human B-cell tumors, results in B-cell depletion (2018) (5)
Interphase cytogenetic characterization of aberrations in the long arm of chromosome 1 in B-cell lymphoid malignancies. (2003) (5)
Treatment and outcome of IG-MYC+ neoplasms with precursor B-cell phenotype in childhood and adolescence (2019) (5)
Molecular characterization of Burkitt lymphoma in the breast or ovary (2021) (5)
The BCR-ABL 1 Kinase Bypasses Selection for the Expression of a Pre – B Cell Receptor in Pre – B Acute Lymphoblastic Leukemia Cells (2004) (4)
Recurrence of Hodgkin's disease after 10 or more years: late relapse or de-novo malignancy due to HLA-DPB1*0301-linked susceptibility? (1997) (4)
Re: B-cell non-Hodgkin's lymphoma: evidence for the t(14;18) translocation in all hematopoietic cell lineages. (1997) (4)
Inv(2)(p23q35) in anaplastic large-cell lymphoma induces constitutive ALK tyrosine kinase activation by fusion to ATIC, an enzyme involved in purine nucleotide biosynthesis (1999) (4)
DNA methylation profiles of bronchoscopic biopsies for the diagnosis of lung cancer (2021) (4)
Inhibition of nuclear export restores nuclear localization and residual tumor suppressor function of truncated SMARCB1/INI1 protein in a molecular subset of atypical teratoid/rhabdoid tumors (2021) (4)
Preimplantation genetic diagnosis (polar body biopsy) and trisomy 21. (2010) (4)
Clinical and genetic features of rhabdoid tumors of the heart registered with the European Rhabdoid Registry (EU-RHAB). (2014) (4)
Maternal uniparental disomy 15 in a fetus resulting from a balanced familial translocation t(2;15)(p11;q11.2) (2010) (4)
Transposable element insertion as a mechanism of SMARCB1 inactivation in atypical teratoid/rhabdoid tumor (2021) (4)
leukemia lymphoid transformation in B-cell precursor acute lymphoblastic , is involved in CRLF2 Deregulated expression of cytokine receptor gene, (2011) (4)
Array‐based profiling of the lymphoma cell DNA methylome does not unequivocally distinguish primary lymphomas of the central nervous system from non‐CNS diffuse large B‐cell lymphomas (2018) (4)
A fresh look to the phenotype in mono-allelic likely pathogenic variants of the leptin and the leptin receptor gene (2021) (4)
Fast Approach for Clarification of Chromosomal Aberrations by Using LM-PCR and FT-CGH in Leukaemic Sample (2011) (4)
Communicating science: epigenetics in the spotlight (2020) (4)
Quantitative DNA Methylation Profiling in Cancer. (2016) (4)
No significantly increased frequency of the inversion polymorphism at the WBS-critical region 7q11.23 in German parents of patients with Williams-Beuren syndrome as compared to a population control (2010) (4)
Prenatal presentation of a metastasizing rhabdoid tumor with homozygous deletion of the SMARCB1 gene. (2010) (4)
Clinical, biological, and molecular genetic features of Richter syndrome and prognostic significance: A study of the French Innovative Leukemia Organization (2021) (4)
Atypical Teratoid/Rhabdoid Tumor (AT/RT) With Molecular Features of Pleomorphic Xanthoastrocytoma (2021) (4)
Lymphoma ‘type K.’—in memory of Karl Lennert (1921–2012) (2013) (4)
Auditing the Editor: A Review of Key Translational Issues in Epigenetic Editing. (2022) (3)
ATRT–SHH comprises three molecular subgroups with characteristic clinical and histopathological features and prognostic significance (2022) (3)
Absence of Non-Canonical, Inhibitory MYD88 Splice Variants in B Cell Lymphomas Correlates With Sustained NF-κB Signaling (2021) (3)
Acquired resistance to DZNep-mediated apoptosis is associated with copy number gains of AHCY in a B-cell lymphoma model (2020) (3)
Mechanisms of Bcl-2 Protein Expression in Diffuse Large B-Cell Lymphoma (DLBCL). (2004) (3)
Peripheral T-cell non-Hodgkin's lymphoma NOS: naming of parts (2006) (3)
Evidence for Antigen-Driven Development of Molecularly Classified Burkitt Lymphomas. (2009) (3)
Double-hit lymphoma of the male breast: a case report (2020) (3)
Assignment1 of the human FAN protein gene (NSMAF) to human chromosome region 8q12→q13 by in situ hybridization (1999) (3)
Impact of a Faulty Germinal Center Reaction on the Pathogenesis of Primary Diffuse Large B Cell Lymphoma of the Central Nervous System (2021) (3)
Chromosom 14-assoziierte Imprintingsyndrome – Temple- und Kagami-Ogata-Syndrome (2015) (3)
Current and Emerging Therapeutic Approaches for Extracranial Malignant Rhabdoid Tumors (2022) (3)
Clinical evidence for a biological effect of epigenetically active decitabine in relapsed or progressive rhabdoid tumors (2021) (3)
Involvement of the CEBP Gene Family in Four IGH@ Chromosomal Translocations in B-Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL). (2005) (3)
outcome microarrays define a leukemic subgroup of disease and predict patient Mantle-cell lymphoma genotypes identified with CGH to BAC (2011) (3)
Infants and Newborns with Atypical Teratoid Rhabdoid Tumors (ATRT) and Extracranial Malignant Rhabdoid Tumors (eMRT) in the EU-RHAB Registry: A Unique and Challenging Population (2022) (3)
Glial papillary tumour of the spinal cord with SMARCB1/INI1‐loss and favourable long‐term outcome (2018) (3)
BCR rearrangement without juxtaposition of ABL in pre-T acute lymphoblastic leukaemia. (1996) (3)
Low‐grade diffusely infiltrative tumour (LGDIT), SMARCB1‐mutant: A clinical and histopathological distinct entity showing epigenetic similarity with ATRT‐MYC (2022) (3)
Treatment stratification in B-cell PTLD after solid organ transplantation (SOT) by international prognostic index (IPI) and response to rituximab: Interim results from the PTLD-2 trial. (2020) (3)
Simultaneous translocations of FGFR3/MMSET and CCND1 into two different IGH alleles in multiple myeloma: lack of concurrent activation of both proto-oncogenes. (2007) (3)
Aberrant Immunoglobulin Class Switch Recombination and Switch Translocations in Activated B Cell-Like Diffuse Large B-Cell Lymphoma. (2006) (3)
PLAGL1 epimutation and bladder exstrophy: Coincidence or concurrent etiology? (2016) (2)
Malignant melanoma and Wiedemann-Beckwith syndrome in childhood. (2010) (2)
SMARCB1-deficient and SMARCA4-deficient Malignant Brain Tumors With Complex Copy Number Alterations andTP53Mutations May Represent the First Clinical Manifestation of Li-Fraumeni Syndrome. (2022) (2)
Differential diagnosis of cyclin D 2 + mantle cell lymphoma ( MCL ) based on fluorescence in sit u hybridization ( FISH ) and quantitative real-time-PCR (2009) (2)
Correction: Deep Bisulfite Sequencing of Aberrantly Methylated Loci in a Patient with Multiple Methylation Defects (2013) (2)
Identification of Posttranvslationally Modified Neoantigens As Targets of B Cell Receptors of Burkitt Lymphoma (2018) (2)
Integrated Somatic Mutation and DNA Methylation Analysis Reveal Genomic and Epigenomic Co-Evolution In Follicular Lymphomas (2013) (2)
Germline Missense Variants in CDC20 Result in Aberrant Mitotic Progression and Familial Cancer (2021) (2)
Identification of a Subset of Peripheral T-Cell Lymphoma, Not Otherwise Specified, Characterized By FOXP3-Positive Regulatory T-Cell Phenotype, HTLV-1 Negativity and Poor Outcome (2014) (2)
Pränataldiagnostik (2019) (2)
Immunoglobulin heavy chain (IGH) locus chromosomal translocations in B-cell precursor acute lymphoblastic leukemia (BCP-ALL): rare clinical curios or potent genetic drivers? (2009) (2)
Clinical and pathological features of Burkitt lymphoma showing expression of BCL 2 – an analysis including gene expression in formalin-fixed paraffin-embedded tissue (2015) (2)
Genetic Obesity in Children: Overview of Possible Diagnoses with a Focus on SH2B1 Deletion (2021) (2)
Identification of Blut, a Novel Long-Noncoding RNA Differentially Expressed in Burkitt Lymphoma (2015) (2)
Autosomal dominant Parkinson’s disease in a large German pedigree (2012) (2)
Quantitative Assessment of Molecular Remission Following Autologous Stem Cell Transplantation Predicts Long Term Remission in Mantle Cell Lymphoma. (2005) (2)
Interphase FISH for the detection of breakpoints in IG loci and chromosomal changes with adverse prognostic impact in multiple myeloma with normal karyotypes. (2006) (2)
Inactivating Gene Alterations of MHC Class II Transactivator CIITA Are Recurrent in Primary Mediastinal B Cell Lymphoma and Hodgkin Lymphoma (2011) (2)
Clinicopathologic Characterization of Cyclin D1-Negative Mantle Cell Lymphoma (2012) (2)
Conflicting results of prenatal FISH with different probes for Down's Syndrome critical regions associated with mosaicism for a de novo del(21)(q22) characterised by molecular karyotyping: Case report (2010) (2)
Absence of Lymphatic Vessels in PCNSL May Contribute to Confinement of Tumor Cells to the Central Nervous System (2016) (2)
Immunohistochemical detection of inhibitor of DNA binding 3 mutational variants in mature aggressive B-cell lymphoma (2016) (2)
Translocations Involving 8q24 in Burkitt Lymphoma and Other Malignant Lymphomas : A Historical Review of Cytogenetics in the Light of Todays Knowledge (2008) (2)
Burkitt's Lymphoma (2011) (2)
Rare Variants in NR2F2 Cause Congenital Heart Defects in Humans. (2016) (2)
suppressor genes as candidate dosage-dependent tumor TRAIL-R2 and TRAIL-R1 Characterization of 8p21.3 chromosomal deletions in B-cell lymphoma: (2011) (1)
Pathogenesis of B-Cell Lymphoma (2019) (1)
Duplication of Chrnb2 in a Patient with Early-Onset Absence Epilepsy (2009) (1)
AT-13THE EU-RHAB EXPERIENCE: CLINICAL, GENETIC AND SURVIVAL DATA DEFINE A STANDARD OF CARE AND ARE THE BASIS FOR CLINICAL TRIALS (2016) (1)
INTEGRATIVE GENOMIC ANALYSIS IDENTIFIES KEY PATHOGENIC CONCEPTS IN PRIMARY MEDIASTINAL LARGE B‐CELL LYMPHOMA (2019) (1)
Simultaneous Fluorescence Immunophenotyping and FISH (FICTION) (2002) (1)
mantle cell lymphoma - D1 CCND2 rearrangements are the most frequent genetic events in cyclin (2013) (1)
[Global gene expression analysis and novel signalling pathways in Hodgkin lymphoma]. (2006) (1)
Endemic Burkitt Lymphoma in second-degree relatives in Northern Uganda: in-depth genome-wide analysis suggests clues about genetic susceptibility (2020) (1)
Janus - a comprehensive tool investigating the two faces of transcription (2013) (1)
Conserved oncogenic module activation patterns (COMAPS) identify biologically homogeneous groups of diffuse large B-cell lymphomas and clearly define Burkitt lymphoma (2008) (1)
Genetically-Defined Diffuse Large B-Cell Lymphoma Subsets Arise By Distinct Pathogenetic Mechanisms and Predict Outcome (2017) (1)
Corrigendum: Recurrent mTORC1-activating RRAGC mutations in follicular lymphoma (2016) (1)
Frequent mutations of FBXO11 highlight BCL6 as a therapeutic target in Burkitt lymphoma. (2021) (1)
Abstract LB-89: Germ-line and somatic SMARCA4 mutations characterize small cell carcinoma of the ovary, hypercalcemic type (2014) (1)
Clinical and Morphologic Features of B-Cell Small Lymphocytic Lymphoma With De 1 ( 6 ) ( q 2 lq 23 ) (2000) (1)
In-Depth miRNA Profiling Of Germinal Center Derived B-Cell Lymphomas By Next Generation Sequencing: A Report From The German Icgc-Mmml-Seq Project (2013) (1)
ETS1 encoding a transcription factor involved in B-cell differentiation is recurrently deleted and downregulated in classical Hodgkin lymphoma Running title: Loss of ETS1 in classical Hodgkin lymphoma (2012) (1)
MDM4 is an essential disease driver targeted by 1q gain in Burkitt lymphoma (2018) (1)
Session 4 : lymphoma genomics (2011) (1)
Homeobox NKX2-3 Is Over-Expressed in Human B-Cell Lymphomas and Drives Marginal Zone B-Cell Lymphomagenesis in Mice (2011) (1)
DNA methylation profile of a hepatosplenic gamma/delta T-cell lymphoma patient associated with response to interferon-α therapy (2020) (1)
Erratum: Rare variants in NR2F2 cause congenital heart defects in humans (The American Journal of Human Genetics (2014) 94 (574-585) (2014) (1)
Seltene Tumordispositionssyndrome (2017) (1)
Human activation-induced deaminase lacks strong replicative strand bias or preference for cytosines in hairpin loops (2022) (1)
Classifying Germinal Center Derived Lymphomas—Navigate a Complex Transcriptional Landscape (2022) (1)
Genome-Wide Detection of DNA Methylation Changes in Lymphomas Using the Infinium ® (2008) (1)
Inv(11)(q21q23) fuses MLL to the Notch co-activator mastermind-like 2 in secondary T-cell acute lymphoblastic leukemia (2006) (1)
Loss of function mutations of BCOR in classical Hodgkin lymphoma (2021) (1)
Rare tumor predisposition syndromes (2017) (1)
Clinical Characteristics and Outcome of Children with Extracranial, Extrarenal Rhabdoid Tumors Registered to the European Rhabdoid Registry 2007–2013 (2014) (1)
FISH and FICTION in Lymphoma Research. (2019) (1)
JOHN ULTMANN MEMORIAL LECTURE: “GENOMES IN TRANSIT: WHAT MULTI‐OMICS CAN TELL US ON LYMPHOMAS” (2017) (1)
[Conventional and multicolor FICTION as tools for the interdisciplinar study of hematological neoplasms]. (2002) (1)
Gene Expression and Proteomic Profiling Predict Therapeutic Response to ABT-737 in Human and Mouse Models of Mantle Cell Lymphoma (2008) (1)
A DNA methylation fingerprint of 1 , 628 human samples Material (2011) (1)
ATRT-09. Outcome and therapeutic interventions in relapsed and refractory ATRT – The EU-RHAB perspective (2022) (1)
Chronic lymphocytic leukemia/small lymphocytic lymphoma with focal D-type cyclin expression in proliferation centers: a report of four cases. (2010) (1)
Splenic infarction associated with rapidly progressive chronic lymphocytic leukemia with complex karyotype and ATM mutation. (2011) (1)
20 Years with SGBS cells - a versatile in vitro model of human adipocyte biology (2022) (1)
CRKL and MAPK1, present in highly amplified region 22q11-12, are novel candidate oncogenes in laryngeal squamous cell carcinoma (2010) (1)
The failure of B cells to induce non-canonical MYD88 splice variants correlates with lymphomagenesis via sustained NF-κB signaling (2020) (1)
Identifying Molecular Markers for the Sensitive Detection of Residual AT/RT Cells (2014) (1)
LINC00892 Is an lncRNA Induced by T Cell Activation and Expressed by Follicular Lymphoma-Resident T Helper Cells (2022) (1)
Successful Retreatment With Venetoclax in a Patient With Chronic Lymphocytic Leukemia (2022) (1)
Focal structural variants revealed by whole genome sequencing disrupt the histone demethylase KDM4C in B-cell lymphomas (2022) (1)
A child with neuroblastoma and metachronous anaplastic sarcoma of the kidney: Underlying DICER1 syndrome? (2020) (1)
IGH@ Translocations Involving the Pseudoautosomal Region 1 (PAR1) of Both Sex Chromosomes Deregulate the Cytokine Receptor-Like Factor 2 (CRLF2) Gene in B Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL) (2008) (1)
Chromosomal and molecular alterations in lymphoid malignancies: basic principles and detection methods (2010) (1)
Epigenome-wide analysis of T-cell large granular lymphocytic leukemia identifies BCL11B as a potential biomarker (2022) (1)
Publisher Correction: Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes (2018) (1)
A Novel FBXO45-Gef-H1 Axis Controls Oncogenic Signaling in B-Cell Lymphoma (2021) (0)
Burkitt lymphoma showing expression of BCL 2 – an analysis including gene expression in formalin-fixed paraffin-embedded tissue (2018) (0)
AT-10ATYPICAL TERATOID RHABDOID TUMORS AND POORLY DIFFERENTIATED CHORDOMAS: DISTINCT MOLECULAR ENTITIES WITH SMARCB1/INI1 LOSS AND DISMAL PROGNOSIS (2016) (0)
Abstract 509: Genomic profiling of acute lymphoblastic leukemia in ataxia telangiectasia patients reveals tight link betweenATMmutations and chromothripsis (2017) (0)
Genetic instability in human chromosome region 3p12-p21 in renal cell carcinoma and lung cancer (2007) (0)
AT-11CRIBRIFORM NEUROEPITHELIAL TUMOR (CRINET): MOLECULAR CHARACTERIZATION OF A SMARCB1-DEFICIENT NON-RHABDOID TUMOR WITH FAVORABLE LONG-TERM OUTCOME (2016) (0)
Molecular Genetics of Lymphomas in Children and Young Adults (2012) (0)
Clonal Architectures Of Bcr-Abl Plus Bcp-All: Implications For Anti B-Cell Directed Therapy (2015) (0)
A modular transcriptome map of mature B cell lymphomas (2019) (0)
Five CCAAT-enhancer-binding-protein gene family members are deregulated by the immunoglobulin heavy chain locus in B-cell precursor acute lymphoblastic leukaemia (2007) (0)
Evidence for a low-penetrant extended phenotype of RTPS1 from a kindred with gain of SMARCB1 exon 6 (2021) (0)
TP53 Mutation Is an Independent Predictor of Poor Survival in Untreated Patients with CD20+ Aggressive B-Cell Lymphoma: Analysis within the Ricover-60 Trial (2012) (0)
TGF-ß on the loose: How downregulation of BAMBI contributes to perturbed signaling in NSCLC (2016) (0)
Poster Presentations (2005) (0)
Deletions of CDKN2A/B and PAX5 are frequently restricted to the CD19+compartment and associated with concurrent deletions of ABL in adult BCR-ABL plus BCP-ALL (2015) (0)
Incidence and genetic characterization of childhood acute lymphoblastic leukemia with CRLF2 overexpression treated according to the AIEOP-BFM ALL 2009 protocol (2015) (0)
Investigation of potential traces of pluripotency in germinal-center-derived B-cell lymphomas driven by MYC (2015) (0)
Epigenome-wide association reveals extensive perturbations in DNA methylation associated with adiposity and its adverse metabolic consequences. Authors (2015) (0)
Prognostic Value of Clinical, Histopathological and Molecular Features in AT/RT (2014) (0)
A 38-year history of an extranodal natural killer cell lymphoma, nasal type (2004) (0)
Determination of DNA Methylation Patterns in Cardiac Tissue from Hypoplastic Left Heart Syndrome (2013) (0)
THE ANALYSIS OF EPIGENOE OF MULTIPE MYELOMA REVEALS A HYPERMETHYLATION OF THE DNA IN SPECIFIC ENHANCER REGIONS OF B CELLS (2015) (0)
Aberrant Expression of and Cell Death Induction by Engagement of the MHC-II Chaperone CD74 in Anaplastic Large Cell Lymphoma (ALCL) (2021) (0)
Erratum (2005) (0)
CONSTRUCTION OF A 3P14 YAC CONTIG WITH MICRODISSECTION CLONES FROM A 3P14-SPECIFIC MICRODISSECTION LIBRARY (1995) (0)
ARRAY‐BASED DNA METHYLOME ANALYSES OF PRIMARY LYMPHOMAS OF THE CENTRAL NERVOUS SYSTEM (2017) (0)
Possible genetic heterogeneity of spinocerebellar ataxia linked to chromosome 15 (2010) (0)
Congenital generalized lipodystrophy type 4 due to a novel PTRF/CAVIN1 pathogenic variant in a child: effects of metreleptin substitution (2022) (0)
Subclonal IKZF1 Deletions Indicate a Multiclonal Evolution In BCR-ABL1-Positive B-Cell Precursor ALL (2013) (0)
Epigenomic Analysis of Acute Myeloid Leukemia Identifies Specific Patterns and Markes with Clinical and Biological Relevance. (2009) (0)
Aberrant Expression of the SOX11 Oncogene in Mantle Cell Lymphoma Is Associated with Activation and De Novo 3D Looping of a Distant Enhancer Element (2016) (0)
Fluorescence in situ hybridization analysis of chromosomal aberrations in solid tumors and hematological malignancies (1995) (0)
Identification of PRDM 16 as a Novel Gene for Cardiomyopathy and a Possible Therapeutic Target for Heart Failure (2013) (0)
Frequent gains of REL and BCL11A in mediastinal B-cell lymphoma selectively provoke up-regulated RNA and protein expression (2007) (0)
COMPARISON OF CONVENTIONAL CYTOGENETIC ANALYSIS AND WHOLE GENOME SEQUENCING IN GERMINAL-CENTER DERIVED B-CELL LYMPHOMAS IN THE FRAMEWORK OF THE ICGC MMML-SEQ PROJECT (2014) (0)
Modified Risk-Stratified Sequential Treatment in B-Cell Post-Transplant Lymphoproliferative Disorder (PTLD) after Solid Organ Transplantation (SOT): The Prospective Multicenter Phase II PTLD-2 Trial (2021) (0)
Deletions of Human Chromosome Region 6q23-24 in B-Lineage Neoplasias (1998) (0)
T-Cells with Extremely Short Telomeres and High Telomerase Activity in T-Cell Prolymphocytic Leukemia (T-PLL): The Ideal Target for Telomerase Inhibition. (2006) (0)
MDM4 Is Targetedby 1qGain andDrivesDisease in Burkitt Lymphoma (2019) (0)
Session 12 : lymphoma and apoptosis (2011) (0)
ATIC, an enzyme involved in purine nucleotide biosynthesis anaplastic lymphoma kinase (ALK) tyrosine kinase activation by fusion to Inv(2)(p23q35) in anaplastic large-cell lymphoma induces constitutive (2013) (0)
1 Transcription factor RFX 7 governs a tumor suppressor network in response to p 53 2 and stress 3 4 (2021) (0)
discordance in systemic lupus erythematosus Changes in the pattern of DNA methylation associate with twin Material Supplemental (2009) (0)
ATRT-14. Malignant rhabdoid tumors of cranial nerves – ATRT or extracranial rhabdoid tumor? (2022) (0)
of diffuse large B-cell lymphoma Patient age at diagnosis is associated with the molecular characteristics (2014) (0)
B‐cell receptors of EBV‐negative Burkitt lymphoma bind modified isoforms of autoantigens (2022) (0)
Atlas of Genetics and Cytogenetics in Oncology and Haematology (2012) (0)
Chromosomal imbalance letter A de novo 1.1 Mb microdeletion of chromosome 19p13.11 provides indirect evidence for EPS15L1 to be a strong candidate for split hand split foot malformation (2011) (0)
Mantle Cell Lymphoma Genotypes Identified with CGH to BAC Microarrays Define Clinical Subgroups of Disease and Strongly Predict Patient Outcome. (2004) (0)
DNA methylation signatures in non-alcoholic fatty liver disease reveal disease-specific signatures and molecular remodelling drivers after weight loss in non-alcoholic fatty liver disease (2013) (0)
Whole-genome epigenomic analysis in multiple myeloma reveals DNA hypermethylation of b-cell specific enhancers (2014) (0)
Secondary cutaneous vasculitislike MALT lymphoma with an IGL-MYC fusion. (2009) (0)
classical Hodgkin and peripheral T-cell lymphoma Chromosomal rearrangements involving the BCL3 locus are recurrent in (2013) (0)
Whole-Genome DNA Methylation Analysis of Mantle Cell Lymphoma: Biological and Clinical Implications (2014) (0)
MUTATIONAL SIGNATURES IN GERMINAL CENTER DERIVED B‐CELL LYMPHOMAS FROM ADULT PATIENTS ANALYZED IN THE ICGC MMML‐SEQ CONSORTIUM (2017) (0)
Five C/EPB gene family members are deregulated by IGH@ in B-cell precursor acute lymphoblastic leukemia. (2006) (0)
Abstract 2479: A functionally nullRAD51Dmissense mutation is strongly associated with ovarian carcinoma (2017) (0)
Aberrant DNA methylation of ADAMTS16 in colorectal and other epithelial cancers (2018) (0)
AT-06THE EXTRAORDINARY CHALLENGE OF TREATING PATIENTS WITH CONGENITAL RHABDOID TUMORS - DATA FROM FRANCE, RUSSIA AND THE EU-RHAB REGISTRY (2016) (0)
Comprehensive Analyses of Genetic Features Identify Coordinate Signatures in Diffuse Large B-Cell Lymphoma (2015) (0)
ATRT-07. Low-grade diffusely infiltrative tumor, SMARCB1-mutant: a clinical and histopathological distinct entity showing epigenetic similarity with ATRT-MYC (2022) (0)
A complicated IVF twin pregnancy (2010) (0)
factors associated with survival translocations : the critical MYC and BCL 2 Lymphomas with concurrent (2009) (0)
Abstract LB-019: FGFR1 abnormalities in seizure-associated familial and sporadic dysembryoplastic neuroepithelial tumors (2016) (0)
CGH microarray analysis uncovers the involvement of specific oncogenes and tumor suppressor genes in multiple myeloma (2004) (0)
9217 DNA reparation genes in genetic and epigenetic susceptibility to Chronic Lymphocytic Leukaemia (2009) (0)
New Insights into Potential Driver Mutations in Pediatric Burkitt Lymphoma (2014) (0)
Next generation sequencing and functional characterization of the androgen receptor (AR) gene in patients with androgen insensitivity syndrome (AIS) and controls (2015) (0)
Vitamins C and E and the Prevention of Preeclampsia (2006) (0)
Significant Differences in the IGVH and BCL6 Mutation Status in Aggressive B-Cell Lymphomas with and without MYC Breakpoints. (2005) (0)
Researcher perspectives on ethics considerations in epigenetics: an international survey (2022) (0)
ATRT-16. CONGENITAL RHABDOID TUMORS AS A MAJOR CLINICAL CHALLENGE - A COLLABORATIVE EUROPEAN EFFORT (2018) (0)
An Activating Mutation (Ser525Pro) within the Transactivation Domain of REL in Two Patients with Human B-Cell Lymphomas Enhances REL ’s In Vitro Transforming Activity. (2005) (0)
Promoter substitution of the oncogene BCL6 as pathogenetically relevant mechanism in primary central nervous system lymphoma (2003) (0)
SAMHD1 is recurrently mutated in T-cell prolymphocytic leukemia (2018) (0)
Abstract 168: Genome-wide survey of CpG methylation across the spectrum of B-cell lymphomas (2010) (0)
Diffuse large B-cell lymphoma in pediatric patients predominantly belong to the germinal-center type B-cell lymphomas* A clinicopathological analysis of cases included in the German BFM- (Berlin- (2006) (0)
LYMPHOID NEOPLASIA CCND2 rearrangements are the most frequent genetic events in cyclin D1 (cid:1) mantle cell lymphoma (2013) (0)
ANTI-ALK ANTIBODIES IN CHILDREN WITH LYMPHOMA WITH VARIANT ALK TRANSLOCATIONS (2011) (0)
NFB-13. Rhabdoid Tumor Predisposition Syndrome (RTPS) – Finding Evidence by systematic Analyses (2022) (0)
‘ ‘ focus on . . . ’ ’ session : profiling and prognosis (2008) (0)
Systematic Evaluation of Somatic Cis-Regulatory Mutations in Follicular Lymphoma (2020) (0)
ATRT-04. Clinical and (epi)genetic characterisation of patients with atypical teratoid/rhabdoid tumor (ATRT) and extracranial malignant rhabdoid tumor conceived following assisted reproduction technologies (ART) (2022) (0)
The use of apolipoprotein D as a biomarker for androgen sensitivity identifies a new type of androgen insensitivity syndrome that is not associated with a mutation in the androgen receptor gene (2016) (0)
BURKITT LYMPHOMA AND HIGH-GRADE B-CELL LYMPHPHOMA WITH 11q ABBERRATIONS SHARE A TRANSCRIPTIONAL PROFILE RESEMBLING A SUBPOPULATION OF EARLY DARK ZONE CELLS (2022) (0)
[FICTION as a new tool to early lung cancer diagnosis]. (2002) (0)
Epigenetics and Epigenomics (2008) (0)
Epigenome-wide association study of body mass index, and the adverse outcomes of adiposity Authors (2016) (0)
Loss of protein expression and recurrent DNA hypermethylation of the GNG7 gene in squamous cell carcinoma of the head and neck (2011) (0)
Novel Fusion of the MALT1/MLT and MAP4 Genes Detected in a Diffuse Large B-Cell Lymphoma. (2005) (0)
Notch1/2 Mutations Are Recurrently Found in Cyclin D1-Negative Sox11-Positive Mantle Cell Lymphoma (2015) (0)
Transcriptome Sequencing in Hypoplastic Left Heart Syndrome Myocardium Reveals Dysregulated Cell Cycle Genes (2013) (0)
Genetic Alterations of the MHC Class II Transactivator CIITA Are Frequent in Primary Mediastinal Large B-Cell Lymphoma and Associated with Diminished MHC Class II Expression (2014) (0)
Detection of SMARCB1 loss in ascites cells in the diagnosis of an abdominal rhabdoid tumor (2015) (0)
MRD Detection in Mantle Cell Lymphoma: Flow Cytometry Is Comparable to Consensus Primer IgH-PCR at Initial Staging, but Less Sensitive Than PCR after Combined Immuno-Chemotherapy. (2005) (0)
Olszak Natural Killer T Cell Function Microbial Exposure During Early Life Has Persistent Effects on (2012) (0)
Mosaic genome-wide maternal isodiploidy: an extreme form of imprinting disorder presenting as prenatal diagnostic challenge (2017) (0)
Tumorigenesis and Neoplastic Progression Aberrant Expression of ID2, a Suppressor of B-Cell-Specific Gene Expression, in Hodgkin’s Lymphoma (2006) (0)
Proffered papers and posters submitted to the Fifth International Symposium on Hereditary Breast and Ovarian Cancer, BRCA : Twenty Years of Advances (2014) (0)
Burkitt lymphoma. (2019) (0)
CLL Subsets with Distinct Stereotyped B Cell Receptors Have Distinct Epigenetic Make-up, Even Beyond IGHV Gene Mutational Status: DNA Methylation Profiling of IGHV-Unmutated CLL Stereotyped Subsets #6 and #8 (2012) (0)
Session 9 : pediatric lymphoma (2011) (0)
Translocations affecting the BCL3 locus in 19q13 are present in a wide spectrum of human lymphomas (2006) (0)
CYTIDINE DEAMINASES SHAPE THE GENOME OF GERMINAL CENTER B CELL DERIVED LYMPHOMA (2021) (0)
Title Primary mucinous adenocarcinoma of the thymic gland with intestinal differentiation and deletion in the HLA-locus : An immunohistochemical and molecular study with review of the Literature (2013) (0)
Follicular Lymphoma "In Situ" and with Partial Lymph Node Involvement Represent Genetically Early Stages of Follicular Lymphoma Development (2011) (0)
Molecular cytogenetic analyses for the detrectoin of chromosomal translocations affecting the BCL3 locus at 19q13 (2003) (0)
lymphoma predominance Hodgkin's lymphoma but not in classical Hodgkin's Frequent occurrence of BCL6 rearrangements in nodular lymphocyte (2013) (0)
Additional molecular findings in 11p15-associated imprinting disorders: an urgent need for multi-locus testing (2014) (0)
classical Hodgkin and peripheral T-cell lymphoma locus are recurrent in BCL3 Chromosomal rearrangements involving the (2013) (0)
AT-01. PITFALLS IN THE DIAGNOSIS OF ATYPICAL TERATOID/RHABDOID TUMORS (AT/RT): EXPERIENCES FROM THE EUROPEAN RHABDOID TUMOR REGISTRY (EURHAB) AND THE INTERNATIONAL CHOROID PLEXUS TUMOR REGISTRY CPT-SIOP (2012) (0)
IDENTIFICATION OF DIFFERENTIALLY METHYLATED DISTANT ENHANCERS RELATED TO ABERRANT EXPRESSION OF SOX11 IN MANTLE CELL LYMPHOMA (2015) (0)
BRIEF DEFINITIVE REPORT generated lentiviral expression constructs allowing coexpres-sion of GFP and either A 20 , I B (2009) (0)
Molecular Characterization of a Novel Chromosomal Translocation t(12;14)(q23;q11.2) in T-Lymphoblastic Lymphoma Between the T Cell Receptor Delta Deleting Elements (TRDREC and TRAJ61) and the Hypothetical Gene C12orf42. (2009) (0)
Epigenetic Regulation of the Cancer Testis Antigen CT45 (2008) (0)
Short communication Detection of translocations involving the HOX11/TCL3 -locus in 10q24 by interphase fluorescence in situ hybridization (2001) (0)
PVRL2 is translocated to the TCRA locus in t(14;19)(q11;13) positive peripheral T-cell lymphoma (2006) (0)
Author Correction to: Endemic Burkitt lymphoma in second-degree relatives in Northern Uganda: in-depth genome-wide analysis suggests clues about genetic susceptibility (2021) (0)
Germline variants in SMARCB1 and other members of the BAF chromatin-remodeling complex across human disease entities: a meta-analysis (2018) (0)
Characterization of the DNA Methylome during Human B-Cell Differentiation (2014) (0)
Evidence for a low‐penetrant extended phenotype of rhabdoid tumor predisposition syndrome type 1 from a kindred with gain of SMARCB1 exon 6 (2021) (0)
Minimal residual disease (MRD) is a predictor of clinical outcome in elderly patients with MCL and identifies patients with long lasting remissions after R-CHOP or R-FC induction followed by maintenance with rituximab or IFN (2011) (0)
Abstracts of the 52nd Workshop for Pediatric Research (2017) (0)
Immunohistochemical detection of ZAP70 in mantle cell lymphoma does not correlate with immunoglobulin heavy-chain variable-region mutation status (2004) (0)
Comprehensive Genomic Analysis of Adult Burkitt Lymphoma Identifies the B-Cell Receptor Signaling Pathway As a Potential Therapeutic Target (2016) (0)
ATRT-05. Infants and newborns with atypical teratoid/rhabdoid tumors (ATRT) and extracranial malignant rhabdoid tumors: a unique and challenging population (2022) (0)
Pathogenic Mutations and Variants in KSR2 in a Cohort of Obese Children (2019) (0)
David York Mason (1941-2008). Antibody wizard and a founder of modern hemopathology (2008) (0)
Molecular and Cellular Pathobiology Molecular Subsets of Mantle Cell Lymphoma De fi ned by the IGHV Mutational Status and SOX 11 Expression Have Distinct Biologic and Clinical Features (2012) (0)
A modular transcriptome map of B-cell lymphomas (2019) (0)
Multiple novel genes are deregulated by IGH@ in B cell precursor acute lymphoblastic leukaemia including five members of the CEBP gene family (2007) (0)
DGCR8 microprocessor defect characterizes familial multinodular goiter with schwannomatosis (2020) (0)
ATRT-06. CLINICAL AND MOLECULAR RISK FACTORS IN CHILDREN WITH ATYPICAL TERATOID/RHABDOID TUMOUR (AT/RT) - EVIDENCE FROM THE EU-RHAB REGISTRY (2018) (0)
DNA methylation profiles of bronchoscopic biopsies for the diagnosis of lung cancer (2021) (0)
Risk of Central Nervous System (CNS) Involvement in Patients with Mantle Cell Lymphoma (MCL): Analysis of Clinico-Biological Factors in a Series of 283 Cases (2014) (0)
“BURKITT-LIKE LYMPHOMA WITH 11Q ABERRATION”: NEITHER BURKITT-LYMPHOMA NOR DIFFUSE LARGE B-CELL LYMPHOMA. WHAT THE MICROENVIRONMENT TELLS US (2022) (0)
Next Generation Sequencing of the Androgen Receptor Gene in Patients With Androgen Insensitivity Syndrome and Controls (2014) (0)
Transient Neonatal Diabetes: the 6q24 phenotype (2001) (0)
938A>C promoter single nucleotide polymorphism - with the BCL2 BCL2 expression in chronic lymphocytic leukemia: lack of association (2013) (0)
Supplementary Material for: Androgen Receptor Mutations Are Associated with Altered Epigenomic Programming as Evidenced by HOXA5 Methylation (2017) (0)
A Novel Pro-Survival Function of Cyclin-D1 Underlies Its Oncogenic Role and Potential as a Therapeutic Target In Mantle Cell Lymphoma (2010) (0)
A unifying hypothesis for PNMZL and PTFL: morphological variants with a common molecular profile (2022) (0)
ATRT-17. ASSISTED REPRODUCTIVE TECHNOLOGIES AND THE DEVELOPMENT OF MALIGNANT RHABDOID TUMOURS (2018) (0)
Molecular characterization of an embryonal rhabdomyosarcoma occurring in a patient with Kabuki syndrome: report and literature review in the light of tumor predisposition syndromes (2022) (0)
GENE-02. GERMLINE MUTATIONS WITHIN THE SWI/SNF COMPLEX PREDICT PATIENTS’ AGE OF ONSET AND TYPE OF DISEASE (2017) (0)
Expression of Cas9 in a Syngeneic Model of Primary Central Nervous System Lymphoma Induces Intracerebral NK and CD8 T Cell-Mediated Lymphoma Cell Lysis Via Perforin. (2022) (0)
No mutations or methylation defects of the candidate tumor suppressor PDCD2 located at 6q27 can be detected in lymphoid neoplasms (2001) (0)
Gene Expression Profiling Signatures Allow the Identification of Unclassifiable Leukemic B-Cell Lymphoid Neoplasms (2015) (0)
Chromosomal aberrations in gray zone lymphomas (2011) (0)
The Gene Expression Profile of T-Cell Prolymphocytic Leukemia with inv(14)(q11q32) Reflects the Pattern of Chromosomal Imbalances. (2006) (0)
Correlation of Peripheral Blood Involvement Measured by Four-Color Flow Cytometry and the Achievement of Molecular Response in Mantle Cell Lymphoma Treated within the Prospectively Randomized Intergroup Trials of the European MCL Network (2007) (0)
ATRT-08. SMARCB1- and SMARCA4-deficient malignant brain tumors with complex copy number alterations andTP53 mutations may represent the first clinical manifestation of Li-Fraumeni syndrome (2022) (0)
leukemia (BCP-ALL) translocations in B-cell precursor acute lymphoblastic IGH recurrent transcription factor family are targeted by CEBP Five members of the (2011) (0)
B-cell malignancies with a t(14;19)(q32;q13) involving the BCL3 locus predominantly derive from IgVH unmutated precursors (2004) (0)
A YAC-contig of human chromosome region 3P14 (2007) (0)
TheBCL11gene family: involvement of BCL11Ain lymphoid malignancies (2001) (0)
Correction: Integrative analysis of genomic variants reveals new associations of candidate haploinsufficient genes with congenital heart disease (2021) (0)
Liquid Biopsies (2016) (0)
Integrating Clinical and Molecular Genetic Data in AT/RT - Results from the European Rhabdoid Registry (EU-RHAB) (2016) (0)
DNA Methylation Changes In Patients With Chronic Lymphocytic Leukemia Relapsing After Treatment Are Not Stochastic But Rather Selectively Affect Critical Pathways For B-Cell Physiology (2013) (0)
Short communication Amplification of ERBB2, RARA , and TOP2A genes in a myelodysplastic syndrome transforming to acute myeloid leukemia (2001) (0)
B-cell lymphoproliferative malignancies iwth t(14;19)(q32;q13) translocation affecting the IGH and BCL3 loci are heterogeneous with regard to somatic hypermutation of the IgVH genes (2003) (0)
Exploration of whole genome and transcriptome sequencing data lacks evidence for oncogenic viral elements to drive the pathogenesis of T-cell prolymphocytic leukemia (2022) (0)
Molecular allelokaryotyping of mantle cell lymphoma (2008) (0)
Different sizes of the duplicated region in partial proximal trisomy 10q syndrome might be caused by rearrangements affecting intrachromosomal repeats (2006) (0)
DNA methylation profiling allows for characterization of atrial and ventricular cardiac tissues and hiPSC-CMs (2019) (0)
Array CGH-based Identification of Aberrations in Patients with complex Phenotypes and Heart Defects (2011) (0)
A new type of transcriptional reprogramming by an IRF4 mutation in lymphoma (2022) (0)
ORIGINAL ARTICLE Pathway activation patterns in diffuse large B-cell lymphomas (2008) (0)
T‐cell prolymphocytic leukemia is associated with deregulation of oncogenic microRNAs on transcriptional and epigenetic level (2022) (0)
Clinical and pathological features of the new WHO-entities large B-cell lymphoma with IRF4 rearrangement and Burkitt-like lymphoma with 11q aberration within the NHL-BFM Group (2018) (0)
ACCUMULATION OF T-CELL WITH EXTREMELY SHORT TELOMERES IN T-CELL PROLYMPHOCYTIC LEUKEMIA (T-PLL) (2013) (0)
FOXM1 haploinsufficiency in acute lymphoblastic leukemia (2017) (0)
RARE-22. GERMLINE PATHOGENIC VARIANT c.1552G>A;p.E518K IN DGCR8 CONFERS SUSCEPTIBILITY FOR SCHWANNOMATOSIS AND THYROID TUMORS (2020) (0)
The short arm of chromosome 18 is a recurrent integration site of a supernumerary BCR/ABL gene fusion in chronic myeloid leukemia. (2007) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Reiner Siebert?

Reiner Siebert is affiliated with the following schools:

Reiner Siebert's Academic­Influence.com Rankings

Why Is Reiner Siebert Influential?

Reiner Siebert's Published Works

Published Works

What Schools Are Affiliated With Reiner Siebert?

Reiner Siebert's AcademicInfluence.com Rankings